id,analyte_A260A280Ratio,vital_status,gender,race,ethnicity,disease_type,tcga_sample_id,cgc_case_uuid,primary_site,age_at_diagnosis,cgc_sample_uuid,cgc_aliquot_uuid,tcga_aliquot_id,tcga_case_id,investigation,days_to_death,tissue_source_site_label,country_of_sample_procurement,pathologic_t_label,pathologic_n_label,histological_diagnosis_label,pathologic_stage_label,PlateCenter,PlateCenterFlag,shannon
13722.58cfa82de4b0c9d6adf6a710,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-34-2600-01A,DA61857A-B00E-4A19-AB02-8FBB2EE56BEA,Lung,76,B0C827C6-B7EF-420B-9A6F-7E8B79C320CC,E9CB8877-8E83-46C0-93F0-EA20530C9400,TCGA-34-2600-01A-01D-0963-08,TCGA-34-2600,TCGA-LUSC,1874,University of Pittsburgh,United States,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,0963-08,FALSE,0.539420531
13722.58cfa82de4b0c9d6adf6a71a,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4389-01A,A3DE401D-91FE-49A2-BB07-81C1A06506E6,Lung,70,ED61AC6A-F21F-4B88-928A-029340D4AEBD,14BF9BFB-14D6-4CAC-A556-828F680E8A15,TCGA-05-4389-01A-01D-1931-08,TCGA-05-4389,TCGA-LUAD,NA,Indivumed,Germany,T1,N0,Lung Adenocarcinoma Mixed Subtype,Stage IA,1931-08,TRUE,0.443417597
13722.58cfa82de4b0c9d6adf6a73a,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4397-01A,6DFD47D2-831A-4386-9051-F78199A16BB5,Lung,65,C4C061CD-E926-400B-B18C-B47C234337CA,0B19BEE7-5281-4915-9D98-C20EB3E84ECF,TCGA-05-4397-01A-01D-1931-08,TCGA-05-4397,TCGA-LUAD,731,Indivumed,Germany,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB,1931-08,TRUE,0.377476704
13722.58cfa82de4b0c9d6adf6a740,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4486-01A,61C655EC-52B5-453F-A6CC-B2ABA445B027,Lung,72,5AE9B10F-347C-48C3-90CD-9290055CFE4B,23D86395-9E20-4CF9-BF7E-F76544A1F772,TCGA-49-4486-01A-01D-1931-08,TCGA-49-4486,TCGA-LUAD,2318,Johns Hopkins,United States,T1,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1931-08,TRUE,0.508956615
13722.58cfa82de4b0c9d6adf6a784,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Kidney Renal Clear Cell Carcinoma,TCGA-BP-5010-01A,9F5C0A43-D222-484A-9249-D288387DD7A1,Kidney,63,4057D69A-52EF-451B-BD74-6436919970C9,A4F8305F-4409-4776-B34D-4878D18C8693,TCGA-BP-5010-01A-02D-2048-08,TCGA-BP-5010,TCGA-KIRC,878,MSKCC,None,T3a,N0,Kidney Clear Cell Renal Carcinoma,Stage III,2048-08,FALSE,0.126383168
13722.58cfa82ee4b0c9d6adf6a7e1,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-91-6840-01A,D5326429-9805-47F9-97B0-FBDA658E3F01,Lung,59,AF744755-51EB-4DAF-9029-5CF88730B1DC,09BC8542-4EA1-4599-91B3-D606425B37E2,TCGA-91-6840-01A-11D-1945-08,TCGA-91-6840,TCGA-LUAD,NA,ABS - IUPUI,United States,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,1945-08,TRUE,0.140619516
13722.58cfa82ee4b0c9d6adf6a7ec,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-5415-01A,713190ED-C6C1-4695-814B-85CA9B95E6A0,Brain,60,E0601D4F-A1DF-4F29-BABA-F8A67556A822,FCA08EE9-B480-4DC7-BE56-F1EB03B56F7C,TCGA-06-5415-01A-01D-1486-08,TCGA-06-5415,TCGA-GBM,NA,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1486-08,FALSE,0.328413899
13722.58cfa82ee4b0c9d6adf6a7e6,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-5429-01A,63BD2175-4B7C-44C9-AEF3-9EFC8F79837B,Lung,60,FBC90B42-7D26-456B-A166-41993A1D3F0D,37D0CF1B-1743-4852-8073-372B16B5C17D,TCGA-05-5429-01A-01D-1625-08,TCGA-05-5429,TCGA-LUAD,NA,Indivumed,Germany,T3,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1625-08,FALSE,0.203993039
13722.58cfa82ee4b0c9d6adf6a894,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-02-2485-01A,521EA765-1BD1-423D-A75D-091243DF37A9,Brain,53,5B5F7C1D-8F3D-4F35-8295-58BC3EEFEAB0,0332B017-17D5-4083-8FC4-9D6F8FDBBBDE,TCGA-02-2485-01A-01D-1494-08,TCGA-02-2485,TCGA-GBM,NA,MD Anderson Cancer Center,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1494-08,TRUE,0.212568552
13722.58cfa82ee4b0c9d6adf6a7ea,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-5153-01A,B3631718-9E0A-454C-BEE1-8F36EBC509D8,Head and Neck,51,2DC7070A-9C70-4BB1-9634-8C934BB9C8D1,24D2B176-B1AB-4789-B394-616B722E63DF,TCGA-BA-5153-01A-01D-2268-08,TCGA-BA-5153,TCGA-HNSC,1762,UNC,None,T2,NX,Head and Neck Squamous Cell Carcinoma,Not available,2268-08,TRUE,0.220751484
13722.58cfa82ee4b0c9d6adf6a8c2,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-CS-6668-01A,A5D3F3FB-6541-419D-B47E-720D438F1BFF,Brain,57,C6784C8A-FA04-429D-9290-40BD95F2D94D,D414E076-DCB6-4EDF-ADEF-0ABDC57354EA,TCGA-CS-6668-01A-11D-1893-08,TCGA-CS-6668,TCGA-LGG,NA,Thomas Jefferson University,United States,Not available,Not available,Oligodendroglioma,Not available,1893-08,FALSE,0.086136122
13722.58cfa82ee4b0c9d6adf6a95a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CR-7385-01A,9F89510C-ED07-471F-B35E-7C87C237B9FE,Head and Neck,42,4C4A6867-BABE-4032-A639-A9B31CDDDC6C,6BBD66DD-EFEE-4D6E-B02F-F88E98526B82,TCGA-CR-7385-01A-11D-2268-08,TCGA-CR-7385,TCGA-HNSC,NA,Vanderbilt University,United States,T1,NX,Head and Neck Squamous Cell Carcinoma,Not available,2268-08,TRUE,0.152140888
13722.58cfa82ee4b0c9d6adf6aa58,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A3AQ-01A,E8F56D0F-EEE4-4DEF-A43A-DEC91F4382A1,Thyroid,85,E13C3F11-913D-4371-9A7D-5E4DF15FB42A,DBACC1AD-C88A-4BCF-A45F-E9C83C762164,TCGA-EM-A3AQ-01A-11D-A20C-08,TCGA-EM-A3AQ,TCGA-THCA,NA,University Health Network,Canada,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A20C-08,FALSE,0.141031827
13722.58cfa82ee4b0c9d6adf6aa12,1.9,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-41-5651-01A,C184C3CA-7AD3-4202-B108-CB9FD5F5D947,Brain,59,90F74516-FB74-4D3F-9D73-5D2BEE2ED381,5FD77BA9-5015-4D8B-86A0-582E5C76BDD6,TCGA-41-5651-01A-01D-1696-08,TCGA-41-5651,TCGA-GBM,NA,Christiana Healthcare,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1696-08,FALSE,0.118532797
13722.58cfa82ee4b0c9d6adf6aa18,1.89,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0157-01A,EA3B5DA2-6A12-400C-BF0F-E442F5EC1132,Brain,63,BD8A1623-5006-4E03-9EB7-0C5A6F9E73D0,B1E62D8E-24D2-4118-8CD0-3142ACEBDD5B,TCGA-06-0157-01A-01D-1491-08,TCGA-06-0157,TCGA-GBM,97,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1491-08,FALSE,0.113487943
13722.58cfa82ee4b0c9d6adf6aab6,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-FD-A3N5-01A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Bladder,69,66559B5F-AB2F-406B-9EDB-0F5085EEC7C5,418A3DEC-96FF-4719-BECB-E1A8260CCE2F,TCGA-FD-A3N5-01A-11D-A21A-08,TCGA-FD-A3N5,TCGA-BLCA,NA,BLN - University Of Chicago,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A21A-08,TRUE,0.138231845
13722.58cfa82ee4b0c9d6adf6aade,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A3PJ-01A,CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A,Bladder,76,29D79B83-FA80-490E-A8A1-C51C9AD061FE,B73523D7-F5A5-4140-8537-4DF4D1ECF465,TCGA-BT-A3PJ-01A-21D-A21Z-08,TCGA-BT-A3PJ,TCGA-BLCA,NA,University of Pittsburgh,United States,T3a,N3,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A21Z-08,TRUE,0.102431787
13722.58cfa82ee4b0c9d6adf6aa8c,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A3PD-01A,39D90499-8549-4DA5-B391-C421F18FACF1,Thyroid,17,A6C23CA9-E6F4-4A2C-BB86-25EF76076381,5BDCA282-C671-48FF-B32B-2380996016C0,TCGA-FE-A3PD-01A-11D-A21Z-08,TCGA-FE-A3PD,TCGA-THCA,NA,Ohio State University,United States,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A21Z-08,TRUE,0.162008071
13722.58cfa82ee4b0c9d6adf6ab28,1.91,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,TCGA-14-1823-01A,A515CF2D-E918-4958-9BF6-E611B425A97E,Brain,58,7EAD0574-478A-4FE1-AABE-34965101B05D,4A1AD661-F6AE-44E8-B50B-72FF658FF22B,TCGA-14-1823-01A-01D-1494-08,TCGA-14-1823,TCGA-GBM,543,Emory University,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1494-08,TRUE,0.110201218
13722.58cfa82ee4b0c9d6adf6ab42,1.95,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13W-01A,3B48CC5E-3396-4DD5-893D-54B75B98B016,Thyroid,45,4DCA97A5-B0E5-4383-8CC5-B6FF07741647,0C18A8B7-BAD1-4AA4-A6DF-472F89D9761C,TCGA-DJ-A13W-01A-11D-A10S-08,TCGA-DJ-A13W,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A10S-08,TRUE,0.183590341
13722.58cfa82ee4b0c9d6adf6ab00,1.9,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,TCGA-14-2554-01A,B1C4579C-72FA-4974-830C-B6A81ACE45F4,Brain,52,E8013962-7049-4596-AA49-E6403F608D98,53DEC97D-0464-4FFD-8E2E-95B2B9A03AF0,TCGA-14-2554-01A-01D-1494-08,TCGA-14-2554,TCGA-GBM,532,Emory University,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1494-08,TRUE,0.093745762
13722.58cfa82ee4b0c9d6adf6ac76,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5932-01A,EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465,Lung,75,7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4,6726C157-F688-491D-8B56-35628645DF89,TCGA-50-5932-01A-11D-1753-08,TCGA-50-5932,TCGA-LUAD,1235,University of Pittsburgh,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1753-08,TRUE,0.040043387
13722.58cfa82ee4b0c9d6adf6ac34,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4280-01A,E0916597-E489-45EF-A8F7-653A3C6591EF,Stomach,78,797D2D3A-F01C-4985-B27C-4E4C2838D34D,388A8875-C3F5-494E-8456-28BE8D3626E1,TCGA-BR-4280-01A-01D-A290-08,TCGA-BR-4280,TCGA-STAD,NA,Asterand,Russia,T2b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage III,A290-08,TRUE,0.178241731
13722.58cfa82ee4b0c9d6adf6ace9,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4443-01A,8CB0144B-BE6B-40A1-86A2-708F96D9B615,Stomach,68,F4FB736A-42C9-4367-A327-D0D1C4CBA359,D8D5585D-32CD-4AC4-B410-A4122A17A558,TCGA-CG-4443-01A-01D-A290-08,TCGA-CG-4443,TCGA-STAD,NA,Indivumed,Germany,T1,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA,A290-08,TRUE,0.07771177
13722.58cfa82ee4b0c9d6adf6aee0,NA,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-HF-7136-01A,647DC54F-A51B-40EA-9D97-C93598C2AF71,Stomach,NA,F6BB75B6-D0C9-49C5-99D0-E658B490C98D,622EAA04-B8F9-471B-98B0-7BEFD119F14C,TCGA-HF-7136-01A-11D-2053-08,TCGA-HF-7136,TCGA-STAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,2053-08,FALSE,0.099060357
13722.58cfa82ee4b0c9d6adf6af48,NA,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-78-7158-01A,501C987E-D1EB-48A9-89EB-72A5062C90B4,Lung,59,EE0D4640-5609-430E-8B80-3058A3F313A8,199BBB0F-996C-40C1-B06D-2066F04BE778,TCGA-78-7158-01A-11D-2036-08,TCGA-78-7158,TCGA-LUAD,179,Prince Charles Hospital,Australia,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB,2036-08,TRUE,0.016233651
13722.58cfa82ee4b0c9d6adf6b056,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-97-8171-01A,397D3F69-1453-4057-B177-8723EEC923D1,Lung,81,84CB5264-6158-40EC-8B65-F96A4A7D6CE4,FA2C3620-7E82-4B12-B135-87986F0F2890,TCGA-97-8171-01A-11D-2284-08,TCGA-97-8171,TCGA-LUAD,NA,Washington University - NYU,United States,T2a,N2,Lung Papillary Adenocarcinoma,Stage IV,2284-08,FALSE,0.034218939
13722.58cfa82ee4b0c9d6adf6a8aa,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-E1-5319-01A,84569C1A-6BAA-4380-AE3C-707DF1BE4618,Brain,48,1EE9478B-84A5-4FFD-8499-F2E02A3A21D7,D252A54E-0377-4B3E-8228-26108EA704FA,TCGA-E1-5319-01A-01D-1893-08,TCGA-E1-5319,TCGA-LGG,2907,Duke,United States,Not available,Not available,Oligodendroglioma,Not available,1893-08,FALSE,0.104844697
13722.58cfa82ee4b0c9d6adf6a8f4,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-CF-A3MF-01A,1E308B12-0590-4DAE-94D0-A539FCF25DF7,Bladder,34,E9889071-4C6E-4761-9D65-06C6B5989FB7,C66C92D5-DF65-46E6-861D-D8A98808E6A3,TCGA-CF-A3MF-01A-12D-A21A-08,TCGA-CF-A3MF,TCGA-BLCA,NA,ILSbio,Vietnam,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A21A-08,TRUE,0.236602675
13722.58cfa82ee4b0c9d6adf6a91a,1.96,Alive,MALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A1QL-01A,E4B08E66-0772-4956-8670-E5C6553EECBE,Thyroid,70,62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0,79169C46-7049-4576-9885-63973DB76AB9,TCGA-DJ-A1QL-01A-11D-A14W-08,TCGA-DJ-A1QL,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A14W-08,TRUE,0.261889417
13722.58cfa82ee4b0c9d6adf6a94c,1.9,Dead,MALE,BLACK OR AFRICAN AMERICAN,Not available,Brain Lower Grade Glioma,TCGA-CS-5395-01A,F86FA219-34E9-4812-8EDF-2B66D7219779,Brain,43,CB40F8BB-879E-496D-AE52-5535B277A952,3D477AC1-3BDF-4410-9594-1A3A1412C6AE,TCGA-CS-5395-01A-01D-1468-08,TCGA-CS-5395,TCGA-LGG,639,Thomas Jefferson University,United States,Not available,Not available,Oligodendroglioma,Not available,1468-08,FALSE,0.006204059
13722.58cfa82ee4b0c9d6adf6a95c,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-7301-01A,84AE73E4-3B39-4444-9BFB-3FC6057EAB32,Brain,53,D6BFF803-8B4A-44A1-AF59-0F2BABA7895F,BA94C29B-B76E-4D67-BF5A-CE6BC45D85F8,TCGA-DU-7301-01A-11D-2086-08,TCGA-DU-7301,TCGA-LGG,788,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,2086-08,FALSE,0.109141005
13722.58cfa82ee4b0c9d6adf6a966,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HW-7487-01A,42251E02-B687-4BF1-A1B6-E3DD978542E4,Brain,39,3040F10C-04E1-4CF8-8EAD-D74C856425C8,C1ABB741-4FCD-4161-B057-C7EFD619CC99,TCGA-HW-7487-01A-11D-2024-08,TCGA-HW-7487,TCGA-LGG,NA,MSKCC,United States,Not available,Not available,Oligodendroglioma,Not available,2024-08,FALSE,0.049823528
13722.58cfa82ee4b0c9d6adf6a974,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1A7-01A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Bladder,67,D68D16F7-6117-4D3D-8347-CF5CD3F23AE4,91F458E6-64B7-454D-A542-B0AA23638FD8,TCGA-DK-A1A7-01A-11D-A13W-08,TCGA-DK-A1A7,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13W-08,TRUE,0.199838119
13722.58cfa82ee4b0c9d6adf6a986,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6407-01A,70939245-41E0-4845-A473-5FEF719B9828,Brain,35,29D91F2B-C040-46BC-9B9E-3A41790DC664,F92A34FA-014E-4B41-A6D0-3B46B8C8A3EE,TCGA-DU-6407-01A-13D-1705-08,TCGA-DU-6407,TCGA-LGG,2875,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,1705-08,FALSE,0.11369096
13722.58cfa82ee4b0c9d6adf6aa80,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A3FQ-01A,FEF9C64F-5959-4DA0-AAA2-66B56FC7B4C3,Thyroid,19,4F88157A-572E-4236-B956-206A9E227DEB,79133E29-BA0B-4E2F-A6D9-BF294C5144F0,TCGA-EM-A3FQ-01A-11D-A21A-08,TCGA-EM-A3FQ,TCGA-THCA,NA,University Health Network,Canada,T3,N1b,Other  specify,Stage I,A21A-08,TRUE,0.33726095
13722.58cfa82ee4b0c9d6adf6aa88,1.89,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1AG-01A,F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5,Bladder,65,64668AA0-DDE5-4534-8CD0-378881E4A4E4,7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C,TCGA-DK-A1AG-01A-11D-A13W-08,TCGA-DK-A1AG,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13W-08,TRUE,0.263668945
13722.58cfa82ee4b0c9d6adf6aaba,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-FT-A3EE-01A,CCE62116-3DCD-400D-ADA0-9839CA02466E,Bladder,80,2356F78C-0653-468F-83DB-6CF6107BD259,FFDD4FEB-ACA3-4104-B1E8-954D705A6450,TCGA-FT-A3EE-01A-11D-A202-08,TCGA-FT-A3EE,TCGA-BLCA,99,BLN - University of Miami,United States,T4a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A202-08,TRUE,0.13710805
13722.58cfa82ee4b0c9d6adf6aac4,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-FD-A3N5-01A,A658BECF-3934-49F2-9E74-291DCA61D4BB,Bladder,69,66559B5F-AB2F-406B-9EDB-0F5085EEC7C5,418A3DEC-96FF-4719-BECB-E1A8260CCE2F,TCGA-FD-A3N5-01A-11D-A21A-08,TCGA-FD-A3N5,TCGA-BLCA,NA,BLN - University Of Chicago,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A21A-08,TRUE,0.157818213
13722.58cfa82ee4b0c9d6adf6aad4,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A3AL-01A,0C50A2C2-1D4C-45CA-9127-F96D4DB18DAF,Thyroid,45,593736E0-1BED-4EAF-BAC9-E90620554F1D,248FD0ED-F14C-40B8-9F14-E9C7ADF16E22,TCGA-EM-A3AL-01A-11D-A202-08,TCGA-EM-A3AL,TCGA-THCA,NA,University Health Network,Canada,T1b,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A202-08,TRUE,0.311469986
13722.58cfa82ee4b0c9d6adf6ab22,1.95,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,TCGA-DK-A1A6-01A,9C274536-3CA1-4F0E-93A8-1688074D862F,Bladder,53,7AD1CD01-0EA2-4FA4-9B05-C280BD256546,DF8A913C-5160-4FC5-950D-7C890E24E820,TCGA-DK-A1A6-01A-11D-A13W-08,TCGA-DK-A1A6,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13W-08,TRUE,0.213872116
13722.58cfa82ee4b0c9d6adf6ab2e,1.95,Alive,MALE,WHITE,Not available,Bladder Urothelial Carcinoma,TCGA-DK-A1A6-01A,9C274536-3CA1-4F0E-93A8-1688074D862F,Bladder,53,7AD1CD01-0EA2-4FA4-9B05-C280BD256546,DF8A913C-5160-4FC5-950D-7C890E24E820,TCGA-DK-A1A6-01A-11D-A13W-08,TCGA-DK-A1A6,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T2a,N1,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13W-08,TRUE,0.20296243
13722.58cfa82ee4b0c9d6adf6ab6c,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1A7-01A,3ED614E7-F356-4D87-985B-D3BBBAE3BB40,Bladder,67,D68D16F7-6117-4D3D-8347-CF5CD3F23AE4,91F458E6-64B7-454D-A542-B0AA23638FD8,TCGA-DK-A1A7-01A-11D-A13W-08,TCGA-DK-A1A7,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A13W-08,TRUE,0.165492484
13722.58cfa82ee4b0c9d6adf6ab86,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-A4IH-01A,BD75D8EE-916B-4ABC-BF33-BCE6A4217076,Head and Neck,57,F87EFB5E-24F5-4D2B-B6B3-987BBDA30E03,B537BC07-9998-49F4-BBBE-5B617152BFD9,TCGA-BA-A4IH-01A-11D-A25T-08,TCGA-BA-A4IH,TCGA-HNSC,NA,UNC,United States,T2,N1,Head and Neck Squamous Cell Carcinoma Basaloid Type,Stage IVA,A25T-08,FALSE,0.110574872
13722.58cfa82ee4b0c9d6adf6aba3,NA,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EL-A3H1-01A,8D54A2ED-03F1-4A23-BDD2-F3395F5D3716,Thyroid,66,9ED0332E-C846-4091-BF6E-0C5BF55B9F1A,62FCEB56-8C6E-4D20-9D2F-5B7042854D23,TCGA-EL-A3H1-01A-11D-A21A-08,TCGA-EL-A3H1,TCGA-THCA,1500,MD Anderson,United States,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A21A-08,TRUE,0.130332853
13722.58cfa82ee4b0c9d6adf6abaa,1.91,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1A5-01A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Bladder,79,A9EF3EC5-B1C1-481F-89CF-1729FAB50173,448FE471-3F4E-4DC8-A4E0-6F147DC93ABE,TCGA-DK-A1A5-01A-11D-A13W-08,TCGA-DK-A1A5,TCGA-BLCA,65,Memorial Sloan Kettering,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A13W-08,TRUE,0.392458054
13722.58cfa82ee4b0c9d6adf6abb8,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A3IL-01A,178B28CD-99C3-48DC-8D09-1EF71B4CEE80,Bladder,79,59D6683F-5EB7-493D-8E8E-78B88BE2CD70,4838B5A9-968C-4178-BFFB-3FAFE1F6DC09,TCGA-DK-A3IL-01A-11D-A20D-08,TCGA-DK-A3IL,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A20D-08,TRUE,0.186354255
13722.58cfa82ee4b0c9d6adf6abd6,NA,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FK-A3SE-01A,AFB00CD4-E5DA-4251-86FB-532C3F65324C,Thyroid,31,D3CC158D-413D-49E6-8D23-3ED89FDEA94A,90883300-D4B6-45D7-AF9A-4E4CE4104500,TCGA-FK-A3SE-01A-11D-A22D-08,TCGA-FK-A3SE,TCGA-THCA,NA,Johns Hopkins,United States,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A22D-08,TRUE,0.145746141
13722.58cfa82ee4b0c9d6adf6ac56,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6452-01A,27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9,Stomach,78,76144F2F-2498-430D-B33C-F000394C427E,C8E961B4-E324-40A2-89F6-736EC3845BC9,TCGA-BR-6452-01A-12D-1800-08,TCGA-BR-6452,TCGA-STAD,NA,Asterand,Russia,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIA,1800-08,TRUE,0.096828161
13722.58cfa82ee4b0c9d6adf6ad73,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A3DV-01A,B46D88E9-8477-4900-8DA9-5E7DBDED0653,Thyroid,68,CE24FE0A-5C4D-4FBE-A02C-76345EAA2892,5DEEAA45-4C1B-4AB2-A487-93C548838F68,TCGA-ET-A3DV-01A-12D-A202-08,TCGA-ET-A3DV,TCGA-THCA,NA,Johns Hopkins,United States,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A202-08,TRUE,0.157197839
13722.58cfa82ee4b0c9d6adf6adb2,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5730-01A,09587F1C-5C99-4102-BC49-84D50FA8D0CE,Stomach,80,2986F11F-3C18-4621-8406-D46614537ED4,26ED0DD6-FCF5-4B45-A3A9-6F813D5FBAF7,TCGA-CG-5730-01A-11D-1600-08,TCGA-CG-5730,TCGA-STAD,NA,Indivumed,Germany,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1600-08,TRUE,0.125330113
13722.58cfa82de4b0c9d6adf6a76e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-1680-01A,1AB7AD70-0F80-41D8-8EFA-3BAEBC8223CC,Lung,63,0BDBE623-CF95-465A-917D-87DFB6A8618E,DD09C7AA-744A-413D-839F-E75E1825F9F9,TCGA-64-1680-01A-02D-1040-01,TCGA-64-1680,TCGA-LUAD,NA,Fox Chase,None,T2a,N2,Lung Adenocarcinoma Mixed Subtype,Stage IV,1040-01,FALSE,0.130483033
13722.58cfa82ee4b0c9d6adf6a8d7,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BL-A13J-01A,556FCBC8-172A-4AF1-8822-AE036E8D68E8,Bladder,65,CF23846D-A7D2-40A9-8B51-49A27967D101,0C7ACA3F-E006-4DE3-AFC2-20B4F727D4FD,TCGA-BL-A13J-01A-11D-A10S-08,TCGA-BL-A13J,TCGA-BLCA,81,Christiana Healthcare,United States,T4,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A10S-08,TRUE,0.220084153
13722.58cfa82ee4b0c9d6adf6a8ec,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7695-01A,5017C115-39B8-4C5C-8BE6-2CB298D7C641,Brain,29,8B58DBF3-022C-4337-9FAD-5AE43B1B84F2,86386B36-2950-4479-B79F-4B347053C8BC,TCGA-HT-7695-01A-11D-2253-08,TCGA-HT-7695,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Oligodendroglioma,Not available,2253-08,FALSE,0.086107934
13722.58cfa82ee4b0c9d6adf6a8e0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DB-5278-01A,010AAC75-3BFE-4BF2-B866-AF0F2D92F125,Brain,17,11437143-41F5-4005-9124-4D6A4A2F0E2D,6847E993-1414-4E6F-A2AF-39EBE218DD7C,TCGA-DB-5278-01A-01D-1468-08,TCGA-DB-5278,TCGA-LGG,NA,Mayo Clinic - Rochester,United States,Not available,Not available,Oligodendroglioma,Not available,1468-08,FALSE,0.079910034
13722.58cfa82ee4b0c9d6adf6a94d,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-5874-01A,1CC53ADE-73C0-492B-A7DC-328269FD0E66,Brain,62,3C7CE3D5-F9E4-4FAE-B033-2058446ED7F3,85D915B8-0184-4EC7-93AD-E9FFA2F5743B,TCGA-DU-5874-01A-11D-1705-08,TCGA-DU-5874,TCGA-LGG,NA,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,1705-08,FALSE,0.084303113
13722.58cfa82ee4b0c9d6adf6a967,2.11,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A20V-01A,24F21425-B001-4986-AEDF-5B4DD851C6AD,Bladder,59,967443E3-35C3-4F41-9BB5-DC899D290806,973D0577-8CA4-44A1-817F-1D3C1BADA151,TCGA-BT-A20V-01A-11D-A14W-08,TCGA-BT-A20V,TCGA-BLCA,154,University of Pittsburgh,United States,T4a,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A14W-08,TRUE,0.114391088
13722.58cfa82ee4b0c9d6adf6a9e5,1.9,Dead,MALE,WHITE,Not available,Glioblastoma Multiforme,TCGA-32-1970-01A,6C5154D2-AF36-492F-B520-D925528824E4,Brain,59,115D06A0-7FFB-4E2F-BC09-59EA55D12894,65723119-BDFE-46F0-B629-C171023ABD71,TCGA-32-1970-01A-01D-1494-08,TCGA-32-1970,TCGA-GBM,468,St. Joseph's Hospital (AZ),None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1494-08,TRUE,0.121728146
13722.58cfa82ee4b0c9d6adf6aa9e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A2LA-01A,797A71EE-372D-41E5-AEEE-5AB3C4661110,Bladder,54,6ED52558-8039-4658-A245-78A29968CE2F,45A7949D-E63F-4956-866C-DF51257032DE,TCGA-BT-A2LA-01A-11D-A18F-08,TCGA-BT-A2LA,TCGA-BLCA,NA,University of Pittsburgh,United States,T3a,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A18F-08,FALSE,0.129745895
13722.58cfa82ee4b0c9d6adf6aaee,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-H4-A2HQ-01A,CEDE5274-279D-4021-8ACA-5ECC4BF94D66,Bladder,64,CBEDC0DB-39FD-4661-9531-CC24D422FAC4,94108975-B7A0-40BA-AD39-E44CC62E8CC0,TCGA-H4-A2HQ-01A-11D-A17V-08,TCGA-H4-A2HQ,TCGA-BLCA,NA,Medical College of Georgia,United States,Not available,NX,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A17V-08,TRUE,0.106713629
13722.58cfa82ee4b0c9d6adf6aaa4,1.91,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0745-01A,386B629E-FAB1-4033-B088-45D6EEB4A13E,Brain,59,6EB5B7FF-1797-4C31-AB5B-6DB2B2641C5B,41D50A3C-49FC-4D8A-9C25-BBBCD3A5DA6F,TCGA-06-0745-01A-01D-1492-08,TCGA-06-0745,TCGA-GBM,239,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1492-08,FALSE,0.265002955
13722.58cfa82ee4b0c9d6adf6ab34,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-BT-A3PH-01A,932BCDD4-5145-49E8-9A95-8A546396F572,Bladder,76,33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67,CDA1A403-16B6-487C-A82A-C377D1D0F89D,TCGA-BT-A3PH-01A-11D-A21Z-08,TCGA-BT-A3PH,TCGA-BLCA,142,University of Pittsburgh,United States,T3b,N2,Muscle invasive urothelial carcinoma (pT2 or above),Stage IV,A21Z-08,TRUE,0.157405934
13722.58cfa82ee4b0c9d6adf6ab40,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-ER-A2NF-01A,D32A4219-4CCA-470F-B6B3-11447D9F5E0B,Skin,53,52EDD1DB-F1C3-4B87-B959-B5B095E52463,0884FDF3-7A20-43BC-BF57-E71F36E11AB9,TCGA-ER-A2NF-01A-11D-A19A-08,TCGA-ER-A2NF,TCGA-SKCM,NA,University of Pittsburgh,None,T4b,N3,Not available,Stage IIIC,A19A-08,TRUE,0.04462236
13722.58cfa82ee4b0c9d6adf6abae,NA,Alive,FEMALE,Not available,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A2Q8-01A,F9CF605F-F287-4EBA-8E8F-8BA47E14ECC4,Thyroid,47,9AF5F9F1-36A3-48EA-A5E1-9B642E609E97,FA837B4D-55A7-4DCF-9FDF-CF9C13644DF7,TCGA-DJ-A2Q8-01A-11D-A18F-08,TCGA-DJ-A2Q8,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1a,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I,A18F-08,FALSE,0.108567118
13722.58cfa82ee4b0c9d6adf6abeb,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7689-01A,D58B535A-6C95-43BB-AD88-0600E6447537,Brain,58,80122820-0D29-4F56-BF14-AC5EEB6F2760,B95CD446-0FED-4DA2-892F-24B39D073AB4,TCGA-HT-7689-01A-11D-2253-08,TCGA-HT-7689,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Oligodendroglioma,Not available,2253-08,FALSE,0.085786015
13722.58cfa82ee4b0c9d6adf6ac86,NA,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-7030-01A,DF576520-A6B6-4C9B-8D06-3F59CC5342FD,Lung,NA,56C937B3-B48F-4662-B992-3265DBB6BC7D,0CE6F3ED-BDBC-4B70-9DB4-2E48F4BF644D,TCGA-75-7030-01A-11D-1945-08,TCGA-75-7030,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T3,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1945-08,TRUE,0.101597956
13722.58cfa82ee4b0c9d6adf6acc0,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-55-6984-01A,F063DDBB-1668-40DF-9EC2-B0A23CA2C389,Lung,71,76C0ADAE-EEF5-459E-A4C9-397D94EBFDCC,309F5324-5608-4F62-B744-5AB268B70927,TCGA-55-6984-01A-11D-1945-08,TCGA-55-6984,TCGA-LUAD,760,International Genomics Consortium,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1945-08,TRUE,0.084089892
13722.58cfa82ee4b0c9d6adf6af24,1.8,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-F1-6177-01A,C3CBA26E-38C2-4569-AFD6-6B045E604808,Stomach,90,0538EFDE-935D-4571-A200-B181AB622447,1D0617E8-2725-4411-B50F-E46EA1D43242,TCGA-F1-6177-01A-11D-1800-08,TCGA-F1-6177,TCGA-STAD,NA,UNC,United States,T1b,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage I,1800-08,TRUE,0.828639863
13722.58cfa82ee4b0c9d6adf6adf6,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4442-01A,8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8,Stomach,85,51927F82-2585-465B-92ED-36EF46D44FAB,7E305F31-FBB0-4BCE-894B-1DD85E303421,TCGA-CG-4442-01A-01D-A290-08,TCGA-CG-4442,TCGA-STAD,NA,Indivumed,Germany,T2,N0,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IB,A290-08,TRUE,1.209605668
13722.58cfa82de4b0c9d6adf6a762,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4432-01A,E737F650-B72D-44E7-B750-558A56716803,Lung,66,2A675528-1ABC-4220-A61A-25109850CE0D,3FBF4DA2-16C9-49AF-A5B3-3DC6C928E75C,TCGA-05-4432-01A-01D-1931-08,TCGA-05-4432,TCGA-LUAD,NA,Indivumed,Germany,T2,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIB,1931-08,TRUE,0.358256977
13722.58cfa82ee4b0c9d6adf6a8a4,1.9,Alive,FEMALE,WHITE,Not available,Brain Lower Grade Glioma,TCGA-CS-6669-01A,DC5BDD21-B23F-400E-BBE2-4C98A517FC9E,Brain,26,57FAE3BD-B822-4855-A4A1-AFDCC20F6071,218A9531-9264-43BC-8535-858D4CB0919E,TCGA-CS-6669-01A-11D-1893-08,TCGA-CS-6669,TCGA-LGG,NA,Thomas Jefferson University,United States,Not available,Not available,Oligodendroglioma,Not available,1893-08,FALSE,0.139404361
13722.58cfa82ee4b0c9d6adf6a85a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HT-7602-01A,799E9106-E62E-4681-8861-137F474EE8B8,Brain,21,0997BB1A-F0A4-4CB8-9714-5BAF9C391CE8,88395C0E-4AFE-434D-8B20-5A3EEF8B7F00,TCGA-HT-7602-01A-21D-2086-08,TCGA-HT-7602,TCGA-LGG,NA,Case Western - St Joes,United States,Not available,Not available,Oligodendroglioma,Not available,2086-08,FALSE,0.089107934
13722.58cfa82ee4b0c9d6adf6a956,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-DU-6401-01A,97CB8701-7D63-4142-B404-006FBB3ECB0B,Brain,31,680DBC4E-5CEC-4E76-848F-72BC0A2407C6,3A81F733-B3A3-4578-B925-A663612BC92C,TCGA-DU-6401-01A-11D-1705-08,TCGA-DU-6401,TCGA-LGG,2660,Henry Ford Hospital,United States,Not available,Not available,Oligodendroglioma,Not available,1705-08,FALSE,0.080234461
13722.58cfa82ee4b0c9d6adf6a99c,NA,Dead,MALE,WHITE,HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-IK-7675-01A,A5F851C5-6130-4EA1-9F86-BE59331A92F7,Brain,43,661F567E-3E63-4692-8EF8-B80A83E6C8DE,A78544D7-65C6-4778-AF62-CEEC24C14056,TCGA-IK-7675-01A-11D-2086-08,TCGA-IK-7675,TCGA-LGG,578,Christiana Healthcare,United States,Not available,Not available,Oligodendroglioma,Not available,2086-08,FALSE,0.12939856
13722.58cfa82ee4b0c9d6adf6ab0e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-HW-7486-01A,55A67639-ED05-4143-AF96-A377BC5489EE,Brain,37,F0C5DF7C-53AA-4D90-8189-44A2BB55A696,67F88CD9-AB77-4227-A8D7-5512246F9772,TCGA-HW-7486-01A-11D-2024-08,TCGA-HW-7486,TCGA-LGG,NA,MSKCC,United States,Not available,Not available,Oligodendroglioma,Not available,2024-08,FALSE,0.086786015
13722.58cfa82ee4b0c9d6adf6ab5f,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5771-01A,3ACD8328-76F7-4F43-9660-394B95748C3D,Prostate,63,19C87DE2-7936-4277-8AA8-3942D36E7579,87E1FFEE-A8CD-4D75-937E-ED415CF43546,TCGA-CH-5771-01A-21D-1576-08,TCGA-CH-5771,TCGA-PRAD,NA,Indivumed,Germany,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1576-08,TRUE,0.05106864
13722.58cfa82ee4b0c9d6adf6a9fd,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A3US-01A,6EE95DC8-2BAC-4691-AFA2-8222E07506AD,Thyroid,37,9F63C13D-6008-416E-9E6B-D4ED4210E569,AD874249-9964-4E48-AA3F-7E828EA28F3F,TCGA-DJ-A3US-01A-11D-A22D-08,TCGA-DJ-A3US,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A22D-08,TRUE,0.168157869
13722.58cfa82ee4b0c9d6adf6ab54,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5788-01A,C039014F-821C-43D6-9D3C-914F9C8D98FA,Prostate,69,144E0265-C04E-4538-A721-94DEF2570486,9E272BEA-9193-4C10-A802-F7E18B2937A3,TCGA-CH-5788-01A-11D-1576-08,TCGA-CH-5788,TCGA-PRAD,NA,Indivumed,Germany,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1576-08,TRUE,0.04281754
13722.58cfa82ee4b0c9d6adf6ab7c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6336-01A,59207BCD-F127-481F-B576-8716DA7D7D97,Prostate,57,34C8B195-ECAB-492B-AED2-43ACFEDEF708,AB318624-DB9D-41D8-B7B8-34712434F28F,TCGA-G9-6336-01A-11D-1786-08,TCGA-G9-6336,TCGA-PRAD,NA,Roswell Park,United States,Not available,N0,Prostate Adenocarcinoma Acinar Type,Not available,1786-08,FALSE,0.036616011
13722.58cfa82ee4b0c9d6adf6ab66,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4512-01A,A1E65587-24C1-4B41-92A7-4E1F15FFFD78,Lung,69,D809A778-D1AC-4406-AB09-67CC70F1F0C2,FA6A60F5-8949-4E01-9435-D3117601627F,TCGA-49-4512-01A-21D-1855-08,TCGA-49-4512,TCGA-LUAD,905,Johns Hopkins,United States,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1855-08,FALSE,0.196468407
13722.58cfa82ee4b0c9d6adf6ab6e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-7791-01A,4FE004E5-49F9-4336-A690-6EBAD512C813,Prostate,67,57ED8A64-46F9-4E1F-8550-CEF121A6BBC6,D32F41FB-0744-4A62-81F6-0260C4920049,TCGA-EJ-7791-01A-11D-2114-08,TCGA-EJ-7791,TCGA-PRAD,NA,University of Pittsburgh,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2114-08,FALSE,0.100502642
13722.58cfa82ee4b0c9d6adf6aba0,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5503-01A,AA252F78-EBF3-42F9-86AF-BB6E57345706,Prostate,50,627B9FF8-2557-4470-824A-B76A8BCD1E9F,25C002F7-E972-421A-B32D-7DD675D81931,TCGA-EJ-5503-01A-01D-1576-08,TCGA-EJ-5503,TCGA-PRAD,NA,University of Pittsburgh,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1576-08,TRUE,0.067421386
13722.58cfa82ee4b0c9d6adf6abf6,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Brain Lower Grade Glioma,TCGA-FG-8182-01A,6A0BCF0C-FA4C-4119-99D2-F722B781D20F,Brain,35,0CF6BE14-2F25-4361-ADE5-7E5B6CA1063E,2AEAAB9F-4459-4BE8-91E7-E0746CBD671C,TCGA-FG-8182-01A-11D-2253-08,TCGA-FG-8182,TCGA-LGG,NA,Case Western,United States,Not available,Not available,Oligodendroglioma,Not available,2253-08,FALSE,0.115337084
13722.58cfa82ee4b0c9d6adf6abd2,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5763-01A,18E79A01-07A2-4CD5-B700-71D41724E041,Prostate,66,F4192448-E5B3-4A9F-8354-9FE28503017A,581BE6CF-9778-49C3-9C77-1316EAA78929,TCGA-CH-5763-01A-11D-1576-08,TCGA-CH-5763,TCGA-PRAD,NA,Indivumed,Germany,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1576-08,TRUE,0.155262026
13722.58cfa82ee4b0c9d6adf6ac26,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-G9-6365-01A,6845076E-E940-4437-8618-81DB4A447544,Prostate,71,95D6E1D3-91C1-40E5-986D-1C5ABB33A03F,769E2AC9-A121-4B2A-A0FD-5F755B579811,TCGA-G9-6365-01A-11D-1786-08,TCGA-G9-6365,TCGA-PRAD,NA,Roswell Park,United States,T4,N0,Prostate Adenocarcinoma Acinar Type,Not available,1786-08,FALSE,0.041043387
13722.58cfa82ee4b0c9d6adf6ac30,NA,Alive,MALE,WHITE,Not available,Prostate Adenocarcinoma,TCGA-HC-7233-01A,E2B33861-2247-413F-B2E5-9BE3B604666C,Prostate,73,848C2C7B-918E-4A09-BAD9-3B3D59BBC101,0C9A5DBC-F7F3-43E7-83D1-77B9FB4B8B54,TCGA-HC-7233-01A-11D-2114-08,TCGA-HC-7233,TCGA-PRAD,NA,International Genomics Consortium,Yemen,T2a,N0,Prostate Adenocarcinoma Acinar Type,Not available,2114-08,FALSE,0.095907545
13722.58cfa82ee4b0c9d6adf6ac40,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-4255-01A,956017BA-5E4B-42C7-B93D-42316874BA93,Stomach,76,A64A7CB8-BA30-45A3-B1DC-2A62D6B1919F,0CD60B96-EB2D-4687-9709-D1455EC45DE7,TCGA-BR-4255-01A-01D-A290-08,TCGA-BR-4255,TCGA-STAD,NA,Asterand,Russia,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,A290-08,TRUE,0.083005348
13722.58cfa82ee4b0c9d6adf6ac22,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7075-01A,5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA,Prostate,63,1FA3E5C2-E415-42FA-AEA3-F6C84959522A,DDC422E4-87E2-4FC0-B56B-DDC2D6A92F58,TCGA-HC-7075-01A-11D-1961-08,TCGA-HC-7075,TCGA-PRAD,NA,International Genomics Consortium,United States,T2a,Not available,Prostate Adenocarcinoma Acinar Type,Not available,1961-08,FALSE,0.075218097
13722.58cfa82ee4b0c9d6adf6ac91,1.9,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,TCGA-22-5477-01A,BD15F523-45C4-4D7C-A3CC-4FB56ABB0E54,Lung,65,F9D568B1-6951-4EAF-8867-4C86BDAEAA04,E7EBC6FB-0926-4C8A-A67B-0C6B9C1FFABA,TCGA-22-5477-01A-01D-1632-08,TCGA-22-5477,TCGA-LUSC,1346,Mayo Clinic - Rochester,United States,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,1632-08,FALSE,0.031414119
13722.58cfa82ee4b0c9d6adf6acae,1.95,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1AA-01A,56D8A1B8-1268-4362-A7F1-77B76FBF1B59,Bladder,57,577700D1-C366-41EF-8A0D-E50DEEFB5E3C,804FFA2E-158B-447D-945C-707684134C87,TCGA-DK-A1AA-01A-11D-A13W-08,TCGA-DK-A1AA,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13W-08,TRUE,0.15925822
13722.58cfa82ee4b0c9d6adf6acbe,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HI-7169-01A,11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6,Prostate,55,AEEF0836-305C-465C-A9CA-6C1825353AE7,E1FC4226-40CE-43B7-B92E-AA7CECD0CF4D,TCGA-HI-7169-01A-11D-2114-08,TCGA-HI-7169,TCGA-PRAD,NA,Fox Chase,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,2114-08,FALSE,0.012407758
13722.58cfa82ee4b0c9d6adf6acb4,1.9,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,TCGA-77-6843-01A,C2598334-F866-4CC3-93EC-2D2E8B85D319,Lung,74,8712518A-FE08-43FD-B497-620ECC0AA0AC,FAB3D6F4-DE1C-4D6C-BDEA-AC39A7884657,TCGA-77-6843-01A-11D-1945-08,TCGA-77-6843,TCGA-LUSC,2224,Prince Charles Hospital,Australia,T1,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA,1945-08,TRUE,0.076380811
13722.58cfa82ee4b0c9d6adf6acc2,1.9,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-23-1124-01A,8A6D2CE3-CC57-451B-9B07-8263782AA23F,Ovary,62,D8246FDA-3072-4470-8A7C-DE05BAC409C2,9A5BB831-8CB8-4DE0-B94B-088CB38DEF1A,TCGA-23-1124-01A-01D-A312-08,TCGA-23-1124,TCGA-OV,1768,Cedars Sinai,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.057024333
13722.58cfa82ee4b0c9d6adf6acee,1.9,Alive,FEMALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-4474-01A,39DD61A8-CD17-4DF3-AE17-61E239EB00BD,Stomach,67,68D21E75-16AC-48D0-B7CA-ABFDE13DED29,5C4B369C-51A3-4CA7-8B9D-2A8E49C0DDE7,TCGA-CG-4474-01A-02D-A290-08,TCGA-CG-4474,TCGA-STAD,NA,Indivumed,Germany,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,A290-08,TRUE,0.159547078
13722.58cfa82ee4b0c9d6adf6ad30,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-43-5670-01A,7D905F8F-3967-4EA8-96C8-17B1B03FBEC3,Lung,70,6B829F48-BA74-40D7-B92F-41A2A2B7D136,369C06F2-8904-49CB-99D1-DD297ED0CD0C,TCGA-43-5670-01A-21D-A320-08,TCGA-43-5670,TCGA-LUSC,NA,Christiana Healthcare,United States,T2b,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA,A320-08,TRUE,0.035218939
13722.58cfa82ee4b0c9d6adf6ad57,1.9,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2766-01A,B913D254-8307-4B8A-8313-D978E32BB38F,Lung,54,09215E83-EDAC-472D-B849-9225C532358C,45E16B70-C3EC-493E-86D1-505FFDF5056C,TCGA-66-2766-01A-01D-1180-08,TCGA-66-2766,TCGA-LUSC,NA,Indivumed,Germany,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA,1180-08,FALSE,0.113825038
13722.58cfa82ee4b0c9d6adf6ad61,1.9,Alive,FEMALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2757-01A,A02932F3-5606-42A5-AEE4-E5B9F5AA1AAA,Lung,65,7C727433-A8A8-44EB-AC11-DCB5EBD9250C,0E2DD8AA-7B45-4E26-BA3C-1A202FCB6BE3,TCGA-66-2757-01A-01D-1180-08,TCGA-66-2757,TCGA-LUSC,NA,Indivumed,Germany,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,1180-08,FALSE,0.032218939
13722.58cfa82ee4b0c9d6adf6adb4,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-92-8064-01A,DC6CEECE-EFAA-4B9D-9E12-D35863D7A902,Lung,58,014AD75E-86D2-423F-B9D3-84657D459A28,0E6654C9-CD5E-4F94-A6D4-54F2BB16DE1F,TCGA-92-8064-01A-11D-2244-08,TCGA-92-8064,TCGA-LUSC,NA,Washington University - St. Louis,United States,T2b,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,2244-08,FALSE,0.079194671
13722.58cfa82ee4b0c9d6adf6ace0,1.9,Alive,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5723-01A,0F00AD32-E4BE-49D4-A02A-D233BFC913C5,Stomach,83,4CCD9CCB-BF50-44EB-AA55-133D8824C433,FFB4F42B-58E9-40C3-8963-11804F041375,TCGA-CG-5723-01A-11D-1600-08,TCGA-CG-5723,TCGA-STAD,NA,Indivumed,Germany,T2,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1600-08,TRUE,0.04381754
13722.58cfa82ee4b0c9d6adf6add4,1.9,Dead,MALE,Not available,Not available,Stomach Adenocarcinoma,TCGA-CG-5724-01A,0B4E8D73-459D-4930-9D1A-ABB8D53E1844,Stomach,59,4D624B21-5AEE-42B8-B192-8AFECB51434D,6DAC8CA0-F776-4EA2-85C4-AEFBA4966BE7,TCGA-CG-5724-01A-11D-1600-08,TCGA-CG-5724,TCGA-STAD,366,Indivumed,Germany,T3,N3,Stomach  Adenocarcinoma  Diffuse Type,Stage IV,1600-08,TRUE,0.103944562
13722.58cfa82ee4b0c9d6adf6adca,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-A4J4-01A,8A24F1A3-4BAB-4591-9676-7BEE01D096C1,Stomach,39,5A5C4538-D75D-4DA5-8E8C-DD92766FEE50,2C316B7E-6A82-4BA1-9F34-D8BFCF82D41E,TCGA-BR-A4J4-01A-12D-A25D-08,TCGA-BR-A4J4,TCGA-STAD,NA,Asterand,Vietnam,T4a,N2,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB,A25D-08,FALSE,0.256218485
13722.58cfa82ee4b0c9d6adf6ae5d,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-37-4135-01A,1F6B2ACA-7357-40D1-BA7A-99227D9900A2,Lung,68,5294476F-A200-453E-9D11-9C50F3C3FA5D,C48D7F4A-E98A-4077-A749-EB9F56F05B84,TCGA-37-4135-01A-01D-A320-08,TCGA-37-4135,TCGA-LUSC,NA,Cureline,Russia,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,A320-08,TRUE,0.276780344
13722.58cfa82ee4b0c9d6adf6aecd,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7744-01A,F6381367-142C-45D0-92B3-C1727D1813CE,Prostate,46,41E0D8F7-E104-43C4-B3BB-FD0B5CB3C7B2,0192D529-7340-45D8-A5F0-249CBB11CA19,TCGA-HC-7744-01A-11D-2114-08,TCGA-HC-7744,TCGA-PRAD,NA,International Genomics Consortium,None,T3b,N0,Prostate Adenocarcinoma Acinar Type,Not available,2114-08,FALSE,0.115523345
13722.58cfa82ee4b0c9d6adf6af06,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-HU-A4G6-01A,30A82E9F-2A2D-4A66-BDB1-26B881C21D01,Stomach,74,41D015E0-E20E-45B7-98F1-3A010F78A8B4,C79CE3D3-4758-4F52-9DA1-38F994C99F4E,TCGA-HU-A4G6-01A-11D-A24D-08,TCGA-HU-A4G6,TCGA-STAD,NA,National Cancer Center Korea,Korea South,T1b,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage IA,A24D-08,FALSE,0.033841496
13722.58cfa82de4b0c9d6adf6a73e,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4422-01A,44DEC838-B653-42A7-A58B-A1FD232CD68C,Lung,68,DACBC55D-25C6-4E86-BD1B-38345B4DF7A7,6D2B0633-5BE4-4026-920C-427D3AA7C763,TCGA-05-4422-01A-01D-1931-08,TCGA-05-4422,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1931-08,TRUE,0.275538372
13722.58cfa82de4b0c9d6adf6a746,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4398-01A,31C96E35-5E2F-429C-B12A-7BC5A497A300,Lung,47,DA010683-C537-478F-8F95-E606B05DBC5C,23D77176-DFED-4BEE-AC96-9934377D8D81,TCGA-05-4398-01A-01D-1931-08,TCGA-05-4398,TCGA-LUAD,NA,Indivumed,Germany,T4,N3,Lung Adenocarcinoma Mixed Subtype,Stage IIIB,1931-08,TRUE,0.194691993
13722.58cfa82ee4b0c9d6adf6af08,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-A4YX-01A,2B4F014F-74E9-4DDA-A1AD-ABCBD124FC44,Stomach,63,DCFF683D-629E-4E67-9E9F-CE5752A2B276,A4C838DF-6AC4-455A-8096-8EC680064374,TCGA-D7-A4YX-01A-11D-A25D-08,TCGA-D7-A4YX,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB,A25D-08,FALSE,0.116133898
13722.58cfa82ee4b0c9d6adf6af46,1.8,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-10-0934-01A,65DDCCD2-70A7-48B3-88E1-9D6FD1DCD11B,Ovary,50,27A33C2D-6704-4164-AA5B-894665DEA55F,0664753B-7566-41E0-8006-7009C6735406,TCGA-10-0934-01A-02D-A312-08,TCGA-10-0934,TCGA-OV,204,MD Anderson Cancer Center,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.063599113
13722.58cfa82ee4b0c9d6adf6af5b,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-09-2050-01A,3C037ACF-F453-4513-A6DD-129163DDDE2A,Ovary,65,239E7813-BA65-4F3C-B7DE-77E166707C75,7A921087-8E62-4A93-A757-FD8CDBE1EB8F,TCGA-09-2050-01A-01D-A312-08,TCGA-09-2050,TCGA-OV,NA,UCSF,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.012407758
13722.58cfa82ee4b0c9d6adf6af82,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6822-01A,E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D,Stomach,77,C30AFDA8-FC63-4228-A9A9-42BCDB562ACE,1021B60D-F7B2-43B0-B2CC-F282D619D533,TCGA-D7-6822-01A-11D-1882-08,TCGA-D7-6822,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB,1882-08,FALSE,0.209291644
13722.58cfa82ee4b0c9d6adf6afd8,1.9,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-10-0938-01A,7CA97692-0BF5-4BBD-81CE-10A051D04BD5,Ovary,80,C11664E8-8883-4A0F-87C3-6FDC903860D5,8093649A-74D6-4832-9154-8CC0182FA381,TCGA-10-0938-01A-02D-A312-08,TCGA-10-0938,TCGA-OV,636,MD Anderson Cancer Center,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.109300067
13722.58cfa82ee4b0c9d6adf6b070,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-60-2722-01A,6FD72426-F6C8-47CA-A500-D5D3600B9B15,Lung,66,060717AD-F034-46FA-8E9B-94A9422E4666,96DC785C-8417-4813-8D15-C32B22D78B74,TCGA-60-2722-01A-01D-1180-08,TCGA-60-2722,TCGA-LUSC,NA,Roswell Park,United States,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB,1180-08,FALSE,0.052198591
13722.58cfa82de4b0c9d6adf6a73c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-43-3920-01A,9293E197-E38A-4E19-A7D0-1B45D1AD48BD,Lung,71,BBC07C89-5540-4217-AA56-3608539983C2,A762DD44-A8AC-4269-8163-BBF6D0F8D4B3,TCGA-43-3920-01A-01D-1553-08,TCGA-43-3920,TCGA-LUSC,NA,Christiana Healthcare,United States,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,1553-08,FALSE,0.67486175
13722.58cfa82de4b0c9d6adf6a738,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-60-2719-01A,585E6487-B0A3-4828-8A06-46BEE01DFF74,Lung,83,DD32EF9A-246B-47C9-A0E3-60A110E9047C,EE6CC68E-8D2A-41EE-82C6-0FECDF7E6259,TCGA-60-2719-01A-01D-1522-08,TCGA-60-2719,TCGA-LUSC,NA,Roswell Park,United States,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,1522-08,TRUE,0.164159929
13722.58cfa82de4b0c9d6adf6a763,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-60-2724-01A,A3E1AC67-A1F2-44FB-8343-A7E8239FC24A,Lung,47,048E7EB0-57A4-4EED-A999-4E46D9FEF885,387C6519-6529-4074-A5AB-00F8052A5732,TCGA-60-2724-01A-01D-1522-08,TCGA-60-2724,TCGA-LUSC,NA,Roswell Park,United States,T3,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA,1522-08,TRUE,0.055024333
13722.58cfa82de4b0c9d6adf6a794,1.9,Dead,MALE,WHITE,Not available,Lung Squamous Cell Carcinoma,TCGA-60-2698-01A,FD9EE494-65FE-4DE4-ADFF-7952A059B17F,Lung,62,A908CE38-12E6-4EC6-BAAB-9D79221AB6EB,2045C788-9EA8-4EA5-A5E3-65FC16A62ADB,TCGA-60-2698-01A-01D-1522-08,TCGA-60-2698,TCGA-LUSC,311,Roswell Park,United States,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB,1522-08,TRUE,0.096745762
13722.58cfa82ee4b0c9d6adf6a918,1.9,Alive,FEMALE,Not available,Not available,Lung Adenocarcinoma,TCGA-75-6203-01A,A8D6694C-A213-4544-AC0B-63BCE16D8F4E,Lung,NA,336EB991-5705-4BC0-A167-6D7F82F81697,D9CD7F95-07D3-4B87-BE83-87340B08D249,TCGA-75-6203-01A-11D-1753-08,TCGA-75-6203,TCGA-LUAD,NA,Ontario Institute for Cancer Research (OICR),Canada,T2,N2,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIIA,1753-08,TRUE,0.106182351
13722.58cfa82ee4b0c9d6adf6aa01,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CR-6487-01A,9AE5101B-6031-4AB1-BFCA-198C41AF3184,Head and Neck,50,027DEDD3-BD53-420E-B7F2-EB5B8C26BCDC,1DB83E80-BDF7-4D8D-8008-BD8406D641FC,TCGA-CR-6487-01A-11D-2268-08,TCGA-CR-6487,TCGA-HNSC,NA,Vanderbilt University,United States,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,2268-08,TRUE,0.158726391
13722.58cfa82ee4b0c9d6adf6aa8a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A2Q2-01A,A00DA907-E527-45F9-9AFB-2FAD2C7B0940,Thyroid,57,A2E3CA88-9FF0-44AD-8C5A-CA4C7B404DE6,565E656C-D5E3-4FE4-A10C-2E9CA1E498B5,TCGA-DJ-A2Q2-01A-11D-A19J-08,TCGA-DJ-A2Q2,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III,A19J-08,FALSE,0.23363014
13722.58cfa82ee4b0c9d6adf6ab5e,NA,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-78-7143-01A,54254F5A-50E8-4150-A9B7-56A0470D2A56,Lung,62,EE72F78D-E5DB-4C99-9034-0B5BBF6DF849,B710996C-8D35-4A2C-BC51-389B3E35B0F3,TCGA-78-7143-01A-11D-2036-08,TCGA-78-7143,TCGA-LUAD,4961,Prince Charles Hospital,Australia,T2,N0,Lung Bronchioloalveolar Carcinoma Nonmucinous,Stage IB,2036-08,TRUE,0.149129735
13722.58cfa82ee4b0c9d6adf6ab20,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-GN-A26C-01A,FA099993-EF30-4EFF-A8FB-AA41B5EA671A,Skin,77,8288B632-9E64-401C-8F45-F268367F40E4,E2774050-1257-4C29-B201-D79CE70FE17E,TCGA-GN-A26C-01A-11D-A19A-08,TCGA-GN-A26C,TCGA-SKCM,821,Roswell,United States,T4b,N2b,Not available,Stage IIIC,A19A-08,TRUE,0.355314062
13722.58cfa82ee4b0c9d6adf6ac51,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6456-01A,1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3,Stomach,74,53369A25-3BC4-48CB-9004-DA3507C4D478,C612570A-881D-421F-98B9-0E4563133744,TCGA-BR-6456-01A-11D-1800-08,TCGA-BR-6456,TCGA-STAD,NA,Asterand,Russia,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB,1800-08,TRUE,0.178363355
13722.58cfa82ee4b0c9d6adf6ac75,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-21-5782-01A,E21964B8-47C7-4A5F-BFA7-7206222883D2,Lung,68,9ABF3A20-B34D-429B-9C13-0468DFC20700,4C2AD4A0-5D57-4E27-9F35-058B2F205F50,TCGA-21-5782-01A-01D-1632-08,TCGA-21-5782,TCGA-LUSC,962,Fox Chase Cancer Center,United States,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,1632-08,FALSE,0.153474246
13722.58cfa82ee4b0c9d6adf6abc6,NA,Alive,MALE,WHITE,HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EL-A3CV-01A,FB83F7D7-2182-4FB7-8E3E-8AD7F1FEAC72,Thyroid,40,7BC433ED-7908-4297-AA5A-E033924BCED1,B1753E9C-29D0-4955-89D2-949CDABD1211,TCGA-EL-A3CV-01A-11D-A19J-08,TCGA-EL-A3CV,TCGA-THCA,NA,MD Anderson,United States,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A19J-08,FALSE,0.118819985
13722.58cfa82ee4b0c9d6adf6ac8b,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-98-8022-01A,ADC853B1-B8BF-488C-A1E2-E95603459B55,Lung,61,95933B01-06CA-4F3E-8995-EB2AB01A2C4C,6962BC97-FBB8-4220-A600-E3C251E245CB,TCGA-98-8022-01A-11D-2244-08,TCGA-98-8022,TCGA-LUSC,NA,Washington University - Alabama,United States,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,2244-08,FALSE,0.12710559
13722.58cfa82ee4b0c9d6adf6ac8f,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-13-1477-01A,13F5814C-1F99-4FFA-84A4-3BBD8979FAAE,Ovary,49,79908395-D442-44A3-8E91-97C3AE97DDD5,0AE2193F-0D68-485A-B8C2-7568CBCCE33E,TCGA-13-1477-01A-01D-A312-08,TCGA-13-1477,TCGA-OV,1662,Memorial Sloan Kettering,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.080194671
13722.58cfa82ee4b0c9d6adf6ac73,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-85-8277-01A,8E6020A1-68DF-4D57-AD4E-33ACC0861FB3,Lung,70,5600CB1A-D0F4-468E-B8D2-E431B77496BF,649F2C20-5B50-40A8-A6FD-9A51F3D5B9DF,TCGA-85-8277-01A-11D-2293-08,TCGA-85-8277,TCGA-LUSC,NA,Asterand,Russia,T3,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA,2293-08,FALSE,0.097876343
13722.58cfa82ee4b0c9d6adf6ac9e,1.9,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-04-1542-01A,0C1A2E7D-E7E4-481E-A012-EF214C444497,Ovary,52,D33FD264-13DB-4642-AFCA-37125751CC28,A0BBB3B1-E774-4C75-9301-BA43FB803F20,TCGA-04-1542-01A-01D-A312-08,TCGA-04-1542,TCGA-OV,2561,Gynecologic Oncology Group,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.063982466
13722.58cfa82ee4b0c9d6adf6ac97,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-13-1487-01A,C9E28934-8379-4511-817C-D787F2C4CA3A,Ovary,74,BFF12F06-DABC-4424-AC53-65CA01D0A406,44EEBC04-C027-45AE-BECA-C4012B494F29,TCGA-13-1487-01A-01D-A312-08,TCGA-13-1487,TCGA-OV,681,Memorial Sloan Kettering,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.018611095
13722.58cfa82ee4b0c9d6adf6aca8,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-HU-A4H0-01A,FE45EAEE-FF0C-4D52-B18C-04DC2D64D3B4,Stomach,72,568CBF5F-86DA-4420-9C70-324D11B8E481,7116CC90-F465-4E7E-AA27-48A83ED258E9,TCGA-HU-A4H0-01A-11D-A25D-08,TCGA-HU-A4H0,TCGA-STAD,NA,National Cancer Center Korea,Korea South,T4a,N3b,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC,A25D-08,FALSE,0.04562236
13722.58cfa82ee4b0c9d6adf6acbc,NA,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,TCGA-HC-8258-01A,DA5B0169-E4F4-4674-B348-220AF03FF4B5,Prostate,56,B8881603-9353-4F63-93D7-E14EFED64AA6,597E4011-EA99-4356-B1D9-8CFE35DB7C3B,TCGA-HC-8258-01A-11D-2260-08,TCGA-HC-8258,TCGA-PRAD,NA,International Genomics Consortium,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2260-08,FALSE,0.061424855
13722.58cfa82ee4b0c9d6adf6acaa,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-68-8250-01A,7B982D5E-3A7D-40AC-BD25-6044C62879B6,Lung,66,A6A1A05E-9126-45CD-B7BE-C1C342FAF5AF,71A2B4A2-88DD-4911-A67E-70B3309C4A12,TCGA-68-8250-01A-11D-2293-08,TCGA-68-8250,TCGA-LUSC,NA,Washington University - Cleveland Clinic,United States,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,2293-08,FALSE,0.064314151
13722.58cfa82ee4b0c9d6adf6acb6,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-23-1118-01A,700E91BB-D675-41B2-BBBD-935767C7B447,Ovary,45,E1BE8AD9-1A52-4677-8436-3DA22AD12E9A,33EA81F2-DB2C-4567-BD7B-4CB9AADFEF88,TCGA-23-1118-01A-01D-A312-08,TCGA-23-1118,TCGA-OV,NA,Cedars Sinai,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.035218939
13722.58cfa82ee4b0c9d6adf6accf,1.9,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-24-1557-01A,7DCC809B-E33A-4453-B92A-C00786F48CB0,Ovary,49,FA79B363-380E-48AE-BB82-DB395085353C,BFF518FB-6DA7-4DFC-AE4C-BD3F641028E2,TCGA-24-1557-01A-01D-A312-08,TCGA-24-1557,TCGA-OV,1213,Washington University,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.050018707
13722.58cfa82ee4b0c9d6adf6acc8,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-8570-01A,1E1CDF72-820F-48A4-8FB6-89575D07CDE9,Stomach,44,E23E2A9C-5080-4276-8982-9CF078027A48,429AAD6F-816D-4739-BAA3-B0EBF2FCD501,TCGA-D7-8570-01A-11D-2340-08,TCGA-D7-8570,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T3,N3a,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIIB,2340-08,FALSE,0.059847332
13722.58cfa82ee4b0c9d6adf6aaec,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EL-A3T0-01A,861F94CE-45FF-4588-ADDB-E1EA48878C2E,Thyroid,45,913D384C-657A-4AE0-9E8E-E9BDB77D140E,54426B1A-E0D3-4D8E-9E81-2D8E6B153B22,TCGA-EL-A3T0-01A-22D-A22D-08,TCGA-EL-A3T0,TCGA-THCA,NA,MD Anderson,United States,T3,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A22D-08,TRUE,0.179401255
13722.58cfa82ee4b0c9d6adf6ace6,2,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5802-01A,0AECAC64-5982-4D76-8F31-958F6A00951D,Stomach,58,93C38FFB-27AC-4C91-939D-7102EE72F404,C1B44966-0F72-4C4F-8783-AB3FFE7F17B2,TCGA-CD-5802-01A-11D-1600-08,TCGA-CD-5802,TCGA-STAD,NA,ILSbio,Vietnam,T3,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1600-08,TRUE,0.097788371
13722.58cfa82ee4b0c9d6adf6ad1a,1.9,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-24-1466-01A,098ACB76-0BF5-44E5-BCAE-F919CF5FA5E5,Ovary,74,3BF6EC5D-E075-41A7-BF32-470EC1F09E98,84CA6AB0-9EDC-4636-9D27-55CDBA334D7D,TCGA-24-1466-01A-01D-A312-08,TCGA-24-1466,TCGA-OV,1373,Washington University,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.159229134
13722.58cfa82ee4b0c9d6adf6ad04,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EL-A3MY-01A,7746BE87-7AD0-48A7-84FB-08A81B220BDB,Thyroid,81,E1C4D037-D70F-4AB1-BB34-554538C934CD,A9C29EDD-2EF1-46EF-93C6-796CF0332A2B,TCGA-EL-A3MY-01A-11D-A21A-08,TCGA-EL-A3MY,TCGA-THCA,533,MD Anderson,United States,T4,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC,A21A-08,TRUE,0.077758255
13722.58cfa82ee4b0c9d6adf6ad22,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A28T-01A,A9D8F797-8A53-4BE5-B957-0F1F6D080390,Thyroid,34,4CA4149A-E952-4A25-9163-8D4C15B09A62,1D97BA51-D981-4986-9F71-C2B6CB9961C3,TCGA-BJ-A28T-01A-11D-A33C-08,TCGA-BJ-A28T,TCGA-THCA,NA,University of Pittsburgh,United States,T1,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A33C-08,FALSE,0.142396847
13722.58cfa82ee4b0c9d6adf6ad24,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-18-3408-01A,D4BC755A-2585-4529-AE36-7E1D88BDECFE,Lung,77,EEFFADF9-2CCB-4937-AE1E-1D50ABA41C4D,24BADF07-8615-48A3-8D6E-45C3D783F18D,TCGA-18-3408-01A-01D-A320-08,TCGA-18-3408,TCGA-LUSC,NA,Princess Margaret Hospital (Canada),Canada,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,A320-08,TRUE,0.136520095
13722.58cfa82ee4b0c9d6adf6ad2e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-56-7582-01A,B5E2CBDA-BBFA-4EF8-A9C4-CB978BEF9B23,Lung,83,1220E8B3-E16E-454E-BC49-60F49F9FE090,89C48E53-C8A9-4518-B3B8-509CDCAFF52B,TCGA-56-7582-01A-11D-A320-08,TCGA-56-7582,TCGA-LUSC,NA,International Genomics Consortium,United States,T2a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,A320-08,TRUE,0.017611095
13722.58cfa82ee4b0c9d6adf6ad1b,1.89,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0221-01A,054F472F-98CB-4559-B2E2-B5F800FC8EEF,Brain,31,6E8D83F2-70BF-44F0-BD64-64D9DFE26F02,96CBA715-CEF0-4E39-92D5-4DEC27E83F1A,TCGA-06-0221-01A-01D-A32W-08,TCGA-06-0221,TCGA-GBM,603,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,A32W-08,FALSE,0.149403467
13722.58cfa82ee4b0c9d6adf6ad33,1.9,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2759-01A,E6B72C24-1607-43B9-8B8A-7BF83EEA5895,Lung,66,33918A59-C2B0-435E-BA63-8A39DA191712,7AC0B303-D685-4FA5-BFEC-34D2BA1DBC8E,TCGA-66-2759-01A-01D-A320-08,TCGA-66-2759,TCGA-LUSC,NA,Indivumed,Germany,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA,A320-08,TRUE,0.102895893
13722.58cfa82ee4b0c9d6adf6ad38,2,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A28V-01A,BED1FB3C-4459-460E-8190-29211857FA73,Thyroid,80,4862B699-580D-4F2E-97A0-BD8918537067,19233FD1-5229-466E-ACF3-5882165758E0,TCGA-BJ-A28V-01A-11D-A19J-08,TCGA-BJ-A28V,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A19J-08,FALSE,0.04462236
13722.58cfa82ee4b0c9d6adf6ad51,1.9,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-24-1614-01A,D3164236-C14A-4230-B527-ECD1A3992F02,Ovary,57,C36E2D42-0759-46F2-8032-B92E555400C9,5CC7C966-499E-49E3-B509-4EEB00EE03D4,TCGA-24-1614-01A-01D-A312-08,TCGA-24-1614,TCGA-OV,1470,Washington University,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.030016686
13722.58cfa82ee4b0c9d6adf6ad63,1.92,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0Z2-01A,F9CEFFC0-D544-418D-B4A9-BD3C84E37026,Thyroid,57,B06B7493-F38A-493F-8B47-61E0FA4D111F,2DD5EEA1-42A1-4E8B-99AC-20399CC7E15C,TCGA-BJ-A0Z2-01A-11D-A10S-08,TCGA-BJ-A0Z2,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC,A10S-08,TRUE,0.078069039
13722.58cfa82ee4b0c9d6adf6ad47,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-68-7755-01A,3666BC65-8E40-409E-9A1F-41583DD6D978,Lung,60,87D21E55-7F4A-4652-B7F7-1E64CB300FAE,84E601B7-DFA5-4CD5-9FEF-07F03967A0D4,TCGA-68-7755-01A-11D-A320-08,TCGA-68-7755,TCGA-LUSC,NA,Washington University - Cleveland Clinic,United States,T1b,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA,A320-08,TRUE,0.063599113
13722.58cfa82ee4b0c9d6adf6ad3e,1.89,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-5579-01A,8B5746F9-DBEE-40BD-9141-1081960CF286,Stomach,74,633DCE5B-7A88-46DC-AD06-8897A609675B,3DB3B7B1-DA1D-4B9C-A92A-C60FECF4328C,TCGA-D7-5579-01A-01D-1600-08,TCGA-D7-5579,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T3,N2,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIIA,1600-08,TRUE,0.11865078
13722.58cfa82ee4b0c9d6adf6ad69,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-25-2400-01A,5C127332-5CA0-45F1-A5AC-4876AD94E491,Ovary,76,B5E8849B-9002-4B65-A2EA-6A46C04ABA4A,D67CAD13-E849-48B0-926C-10B6046BA0B9,TCGA-25-2400-01A-01D-A312-08,TCGA-25-2400,TCGA-OV,1278,Mayo Clinic - Rochester,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.140556667
13722.58cfa82ee4b0c9d6adf6ad3a,2,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A0ZB-01A,DC4D8468-6F34-40CB-A826-8D582CD86FDE,Thyroid,66,145A474E-D262-468A-8DB7-EE9F1B7CE0A7,ADD0B0F6-B4A8-4B73-B634-C3600DC567D5,TCGA-BJ-A0ZB-01A-11D-A10S-08,TCGA-BJ-A0ZB,TCGA-THCA,NA,University of Pittsburgh,United States,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A10S-08,TRUE,0.091216623
13722.58cfa82ee4b0c9d6adf6ad8a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-6564-01A,AF1086CC-B330-4AD6-AE1C-3B5C7259949A,Stomach,46,B8355E52-D7A7-4711-BBA7-BC4D201741F2,2E66EB75-097C-4AD8-B2B3-9F5849DFD02F,TCGA-BR-6564-01A-12D-1882-08,TCGA-BR-6564,TCGA-STAD,NA,Asterand,Russia,T3,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIA,1882-08,FALSE,0.140345769
13722.58cfa82ee4b0c9d6adf6ad43,1.9,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2744-01A,1EE543D5-B8C0-4F79-8373-6BB6319F2EE2,Lung,71,75E00DD8-0AD9-4447-9407-0AB6AC0A7173,706868B5-4920-433A-BEA3-92E9BF83059B,TCGA-66-2744-01A-01D-A320-08,TCGA-66-2744,TCGA-LUSC,NA,Indivumed,Germany,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB,A320-08,TRUE,0.155343992
13722.58cfa82ee4b0c9d6adf6ad7a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-8381-01A,AEF8D98F-7A1C-47F3-B5A7-A3CB299C70DE,Stomach,51,1DDC7F73-D793-4AE6-8A6A-851069892FAD,D6738C83-7B52-4224-846A-67BD085AAAB8,TCGA-BR-8381-01A-11D-2394-08,TCGA-BR-8381,TCGA-STAD,NA,Asterand,Ukraine,T3,N1,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIB,2394-08,TRUE,0.079194671
13722.58cfa82ee4b0c9d6adf6ad9a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-96-7545-01A,4CA13C92-84B4-4EDF-842A-B20B7E713415,Lung,73,59F2654E-7F41-480B-B59C-F0DB373B7160,B7A7D93B-38A7-4FC3-A433-3BB0A8CB7C42,TCGA-96-7545-01A-21D-A320-08,TCGA-96-7545,TCGA-LUSC,NA,Washington University - NYU,United States,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,A320-08,TRUE,0.372388611
13722.58cfa82ee4b0c9d6adf6ada0,2,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-5799-01A,C991697F-77F9-412A-9BD1-0E47F7387CB2,Stomach,45,A3180E0E-EB99-49DD-8252-5FEA05A9885F,EB59B79F-BD36-4BF4-83E3-2AF73BD1D30A,TCGA-CD-5799-01A-11D-1600-08,TCGA-CD-5799,TCGA-STAD,NA,ILSBIO,Vietnam,T2,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage II,1600-08,TRUE,0.100812888
13722.58cfa82ee4b0c9d6adf6adda,1.9,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-18-3415-01A,9A874B64-D0D6-416E-97BC-E9071ED0B16B,Lung,77,23327C39-2E21-4604-9EBA-15884AE356FC,34881C6B-F59F-42C0-9F29-9C5C47262AE6,TCGA-18-3415-01A-01D-A320-08,TCGA-18-3415,TCGA-LUSC,NA,Princess Margaret Hospital (Canada),Canada,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,A320-08,TRUE,0.098530101
13722.58cfa82ee4b0c9d6adf6add8,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-25-1634-01A,15556B28-C6BD-455A-87B6-4B7B3E33D0E4,Ovary,75,C0091BB4-1079-4254-AD42-42AC1DDD7F1E,3A5EAED6-FCFD-437A-B61C-FD3725C64717,TCGA-25-1634-01A-01D-A312-08,TCGA-25-1634,TCGA-OV,1091,Mayo Clinic - Rochester,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.129380046
13722.58cfa82ee4b0c9d6adf6adfc,1.88,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0211-01A,5C984433-33CF-42FC-B3BA-511EFCDCAB19,Brain,47,83177103-6AE2-444E-8AE7-E1BF76B1351D,CAEF21A2-190E-456D-95C9-3927A0B250AC,TCGA-06-0211-01A-01D-1491-08,TCGA-06-0211,TCGA-GBM,360,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1491-08,FALSE,0.172579921
13722.58cfa82ee4b0c9d6adf6ae46,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-33-4586-01A,376DFD27-68E8-4A1A-9C4F-5064279B2A9E,Lung,57,A41992A4-D0F9-4D5B-8D05-0E3025D9C8FF,B88F014E-BC0F-4775-8228-39E0B471C3B0,TCGA-33-4586-01A-01D-A320-08,TCGA-33-4586,TCGA-LUSC,428,Johns Hopkins,United States,T2,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA,A320-08,TRUE,0.066797053
13722.58cfa82ee4b0c9d6adf6ae1a,1.9,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2795-01A,DA93A143-5799-4856-A5F4-3FF3B9284311,Lung,68,9DC330BF-ACBD-4419-B533-35CF59ACEC71,D18C6E64-9598-488A-8AB3-3652072F9277,TCGA-66-2795-01A-02D-A320-08,TCGA-66-2795,TCGA-LUSC,NA,Indivumed,Germany,T4,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB,A320-08,TRUE,0.851237683
13722.58cfa82ee4b0c9d6adf6ae76,2.03,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A22Z-01A,78D14F86-896A-4F98-9274-B2E8E387ADD9,Thyroid,61,D206D300-E0CE-4A40-AF1F-45A685346A6E,8845FCE6-E2B4-4929-942B-57096B0BBAFC,TCGA-FE-A22Z-01A-11D-A35R-08,TCGA-FE-A22Z,TCGA-THCA,NA,Ohio State University,United States,T4a,N1,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVA,A35R-08,FALSE,0.223105398
13722.58cfa82ee4b0c9d6adf6ae79,1.9,Dead,FEMALE,WHITE,Not available,Glioblastoma Multiforme,TCGA-14-1402-01A,BF339349-062F-4EA9-A0B2-D87D3A21099E,Brain,58,90A6DB9D-669E-4507-A0B9-B1C5D8F5BF4D,6FEE80F8-11CB-4DE7-ADED-E586708D2368,TCGA-14-1402-01A-01D-1493-08,TCGA-14-1402,TCGA-GBM,975,Emory University,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1493-08,FALSE,0.103773842
13722.58cfa82ee4b0c9d6adf6ae86,1.9,Dead,FEMALE,Not available,Not available,Glioblastoma Multiforme,TCGA-14-1034-01A,0078B0C4-68A9-483B-9AAB-61156D263213,Brain,60,F2FFA9FF-86D6-41EF-92E7-7F87E981985B,86CD18AE-6390-4669-A707-4E0E334C690A,TCGA-14-1034-01A-01D-1492-08,TCGA-14-1034,TCGA-GBM,485,Emory University,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1492-08,FALSE,0.093987146
13722.58cfa82ee4b0c9d6adf6ae81,1.89,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0210-01A,DE7B7CAC-F094-4D59-8651-E991E34EA093,Brain,72,D56A1EB8-D47B-41C3-B5D0-F5632DF77B3F,E362F533-5394-4E4A-9E4A-375FFC5F427B,TCGA-06-0210-01A-01D-1491-08,TCGA-06-0210,TCGA-GBM,225,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1491-08,FALSE,0.139242517
13722.58cfa82ee4b0c9d6adf6ae8a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-L6-A4ET-01A,E1FF7694-64E1-47ED-B0D8-34ACFB4FFEF1,Thyroid,49,D6183BCA-9A4D-41AC-940D-0EAA23DECF56,546B97B0-AB82-42A1-BBD2-241523278EC3,TCGA-L6-A4ET-01A-11D-A257-08,TCGA-L6-A4ET,TCGA-THCA,NA,National Institutes of Health,United States,T3,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC,A257-08,FALSE,0.064314151
13722.58cfa82ee4b0c9d6adf6ae91,1.87,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0125-01A,8DA3103E-3E6C-4176-A583-D5FE5E60601E,Brain,63,3A30326B-7523-4565-9A7E-0F7B5536B1CA,0D2A3D87-8ED4-4B27-82EB-FDE852EDE1D7,TCGA-06-0125-01A-01D-1490-08,TCGA-06-0125,TCGA-GBM,1448,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1490-08,FALSE,0.119323828
13722.58cfa82ee4b0c9d6adf6ae8b,1.91,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EM-A22O-01A,6ABC861A-376D-446B-ACEE-FB0F03A82C09,Thyroid,75,AACF33BD-95CE-40FD-9828-1E78CBBB0E1B,13642CF8-9840-4A7D-A26A-95F65B2C70C3,TCGA-EM-A22O-01A-11D-A17V-08,TCGA-EM-A22O,TCGA-THCA,NA,University Health Network,Canada,T4a,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A17V-08,TRUE,0.13001032
13722.58cfa82ee4b0c9d6adf6ae9a,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FK-A3SD-01A,63B01B43-A68A-4046-89B0-736BA4D08504,Thyroid,61,B48D226E-610A-40DC-B62A-6DB863A7366C,29578759-9CCB-4A24-B5B8-C45EBD4339D9,TCGA-FK-A3SD-01A-11D-A22D-08,TCGA-FK-A3SD,TCGA-THCA,NA,Johns Hopkins,United States,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A22D-08,TRUE,0.174836231
13722.58cfa82ee4b0c9d6adf6aebe,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0190-01A,74139255-A635-4C87-814D-3DD04ED630A8,Brain,62,5E92A5D5-77A4-401A-ADE3-E01C95302EC0,640AFBF7-7886-4A29-9505-DCF36B611A05,TCGA-06-0190-01A-01D-1491-08,TCGA-06-0190,TCGA-GBM,317,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1491-08,FALSE,0.230081098
13722.58cfa82ee4b0c9d6adf6aea8,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-8373-01A,60879669-96C2-4710-82E0-0AE9D0E5B242,Stomach,65,4370B4F3-4FD7-4558-BF59-DAAE486BADC3,1F2A8889-4374-4037-BB56-0F20733380E3,TCGA-BR-8373-01A-11D-2340-08,TCGA-BR-8373,TCGA-STAD,NA,Asterand,Ukraine,T4a,N1,Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIA,2340-08,FALSE,0.050446084
13722.58cfa82ee4b0c9d6adf6aab8,1.9,Alive,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CR-6482-01A,468649E7-1525-4B8A-8AB5-DDB27DB5F022,Head and Neck,62,92173F97-B46A-4950-8CD8-6729AB9522C5,7158C9FD-A633-4FEF-AA23-BD285F2A87A8,TCGA-CR-6482-01A-11D-2268-08,TCGA-CR-6482,TCGA-HNSC,NA,Vanderbilt University,United States,Not available,Not available,Head and Neck Squamous Cell Carcinoma,Not available,2268-08,TRUE,0.117992106
13722.58cfa82ee4b0c9d6adf6aea6,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A2OW-01A,A65EC434-9AE0-453F-B440-08BF25558FD1,Thyroid,37,4D6A2D9E-EC25-4040-A696-2D8D5D5C392E,17A66D24-DE77-4F2A-A8AD-D2C6A69E7671,TCGA-EM-A2OW-01A-11D-A202-08,TCGA-EM-A2OW,TCGA-THCA,NA,University Health Network,Canada,T1b,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A202-08,TRUE,0.173384985
13722.58cfa82ee4b0c9d6adf6aed0,1.9,Dead,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-13-1491-01A,C8FEBEEF-8E7E-459E-88CB-8086692DC559,Ovary,55,A082B848-0867-4BB4-96BA-008645D9053C,129DE5B2-D9B0-4762-9EF8-72D98231FB50,TCGA-13-1491-01A-01D-A312-08,TCGA-13-1491,TCGA-OV,1595,Memorial Sloan Kettering,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.121870271
13722.58cfa82ee4b0c9d6adf6aebf,2.03,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DE-A0Y3-01B,C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7,Thyroid,60,3AE03B86-1473-409C-8118-A91A73A36F60,7DFCFE29-3900-4D7B-8067-60C51584B0B1,TCGA-DE-A0Y3-01B-11D-A10S-08,TCGA-DE-A0Y3,TCGA-THCA,NA,University of North Carolina,United States,T4a,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVC,A10S-08,TRUE,0.089416725
13722.58cfa82ee4b0c9d6adf6aeea,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A3FR-01A,2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4,Thyroid,55,319E3498-D5FB-4142-A09F-ABA779DBC094,4BAE2F08-DA75-4991-ACB8-5BA9912F9131,TCGA-EM-A3FR-01A-11D-A21Z-08,TCGA-EM-A3FR,TCGA-THCA,NA,University Health Network,Canada,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A21Z-08,TRUE,0.046244917
13722.58cfa82ee4b0c9d6adf6aee2,NA,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-ET-A2N1-01A,E74B8474-F74A-498D-8848-6AA97D38D2D8,Thyroid,47,1EFC40AF-FEDF-4BC3-BE59-1E31A87BAA15,7ED3E66E-F784-483F-AC37-1300736584A4,TCGA-ET-A2N1-01A-11D-A18F-08,TCGA-ET-A2N1,TCGA-THCA,NA,Johns Hopkins,United States,T2,N1a,Thyroid Papillary Carcinoma - Classical/usual,Stage III,A18F-08,FALSE,0.074314151
13722.58cfa82ee4b0c9d6adf6af26,1.9,Dead,FEMALE,WHITE,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-24-1562-01A,4C18D9CF-4AF4-4A86-8B1C-F78795FBBD7E,Ovary,67,A323F2F5-B250-40A6-A318-084A3933E829,E9D98643-01EE-40C3-A617-E004559625CD,TCGA-24-1562-01A-01D-A312-08,TCGA-24-1562,TCGA-OV,1384,Washington University,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.04862236
13722.58cfa82ee4b0c9d6adf6af2a,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-HU-8608-01A,C6316FB5-99A7-4ADF-832F-DCE44DDCD3AA,Stomach,70,E70FE3AD-F9FA-4097-B472-86606C241D26,A2EE5DDE-4342-4E78-88C5-3C9A8E10CBF5,TCGA-HU-8608-01A-11D-2394-08,TCGA-HU-8608,TCGA-STAD,NA,National Cancer Center Korea,Korea South,T4a,N2,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB,2394-08,TRUE,0.041420831
13722.58cfa82ee4b0c9d6adf6af4a,1.9,Dead,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2793-01A,9AF6ED4E-8CDC-4F49-84E9-BA1053B5B3CA,Lung,68,DAA128EB-BF5A-4C2C-A7DC-E6E06B6AEB85,7DC5F8BA-0080-43D3-8426-BD527A970761,TCGA-66-2793-01A-01D-1267-08,TCGA-66-2793,TCGA-LUSC,306,Indivumed,Germany,T4,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB,1267-08,FALSE,0.126833228
13722.58cfa82ee4b0c9d6adf6af3a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-13-0912-01A,58D34254-4F5B-40A4-9E9F-7160062FB2A4,Ovary,58,BFC06061-2299-4785-9943-67F5EC9EBE3F,95FC38AC-2B36-4C46-ABBF-8D2D52FF9626,TCGA-13-0912-01A-01D-A312-08,TCGA-13-0912,TCGA-OV,NA,Memorial Sloan Kettering,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.06635991
13722.58cfa82ee4b0c9d6adf6af1c,NA,Alive,MALE,WHITE,HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-FP-7998-01A,B2E2D35C-7A79-4165-97A5-82D5C37D94F2,Stomach,77,0A95BD32-539E-43F3-9694-A7D033A6FA84,172C9864-C26D-4E9B-947A-E8CE761E996D,TCGA-FP-7998-01A-11D-2201-08,TCGA-FP-7998,TCGA-STAD,NA,International Genomics Consortium,United States,T4a,N3a,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIC,2201-08,FALSE,0.086155146
13722.58cfa82ee4b0c9d6adf6af4c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-18-4721-01A,19F0CB8C-2E57-4310-967F-A9890F1605DB,Lung,74,1BAC4FF6-E35B-40F6-BBE4-705AB672D102,D2AB2555-7288-47A4-A80C-BF62D65B67B8,TCGA-18-4721-01A-01D-1441-08,TCGA-18-4721,TCGA-LUSC,NA,Princess Margaret Hospital (Canada),Canada,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,1441-08,FALSE,0.060172442
13722.58cfa82ee4b0c9d6adf6af7e,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-25-1632-01A,C435627C-159D-4A6D-A819-30ABAC24BF4D,Ovary,68,ED9C97D8-4DF2-4ED3-B455-4955D72901A8,FF3FE4A3-7D19-4D4D-81B6-AAA41BA5BF39,TCGA-25-1632-01A-01D-A312-08,TCGA-25-1632,TCGA-OV,1799,Mayo Clinic - Rochester,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.050018707
13722.58cfa82ee4b0c9d6adf6af78,1.87,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-EQ-5647-01A,2D291FA3-F0FD-4BC1-91A6-783863714190,Stomach,86,400FED84-FE61-4F7A-9DCC-6C32131106CD,FECCEE20-A62D-4152-B832-B9FDACA87A61,TCGA-EQ-5647-01A-01D-1600-08,TCGA-EQ-5647,TCGA-STAD,19,Christiana Healthcare,United States,T4,N3,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IV,1600-08,TRUE,0.040420831
13722.58cfa82ee4b0c9d6adf6af6c,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-13-0906-01A,E43D3769-E25F-4FB7-9080-EA26DEFAF094,Ovary,50,A0C48680-3CAF-49BD-B495-C9FD3A9CBE76,42AF8F74-FD4B-486D-BC11-DB53CC471D62,TCGA-13-0906-01A-01D-A312-08,TCGA-13-0906,TCGA-OV,NA,Memorial Sloan Kettering,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.087221545
13722.58cfa82ee4b0c9d6adf6af68,1.9,Dead,FEMALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-22-5492-01A,422A46B2-A67C-4A7E-923F-9B651CED96F8,Lung,73,8A0B8A54-D4F7-4911-A692-6731D089EBA2,ABC94013-71F5-4AC6-88A4-01B4EF9F9D2F,TCGA-22-5492-01A-01D-1632-08,TCGA-22-5492,TCGA-LUSC,506,Mayo Clinic - Rochester,United States,T2a,N2,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIA,1632-08,FALSE,0.076413277
13722.58cfa82ee4b0c9d6adf6af04,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-HU-8245-01A,4E9D13DA-438D-4B5E-8E86-67432B5E9471,Stomach,72,5CD8D6FC-F68E-4C14-93B0-BABE544C7A63,61CAD26A-CBC6-4977-83B9-DC61E49F2861,TCGA-HU-8245-01A-11D-2340-08,TCGA-HU-8245,TCGA-STAD,NA,National Cancer Center Korea,Korea South,T3,N0,Stomach Intestinal Adenocarcinoma Papillary Type,Stage IIA,2340-08,FALSE,0.088268983
13722.58cfa82ee4b0c9d6adf6afb0,1.9,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,Not available,Ovarian Serous Cystadenocarcinoma,TCGA-24-1544-01A,21F6BF91-DFC6-4A59-8B76-88A0F95C7B47,Ovary,71,CF7B9151-6479-41AF-986C-D9DB10E33CA6,052665D1-AB75-4F40-BE5A-B88154C8BEED,TCGA-24-1544-01A-01D-A312-08,TCGA-24-1544,TCGA-OV,820,Washington University,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.062424855
13722.58cfa82ee4b0c9d6adf6affa,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Ovarian Serous Cystadenocarcinoma,TCGA-13-0727-01A,90F4B65C-CFD4-4066-A5B9-842885C172E2,Ovary,71,6FCD7BB8-6CB0-4797-A5B5-D3EC4911A279,16DF7888-2480-4394-8856-D57A6EF371D2,TCGA-13-0727-01A-01D-A312-08,TCGA-13-0727,TCGA-OV,462,Memorial Sloan Kettering,None,Not available,Not available,Serous Cystadenocarcinoma,Not available,A312-08,TRUE,0.050024333
13722.58cfa82ee4b0c9d6adf6aeee,2.05,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FE-A233-01A,E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB,Thyroid,18,76A6F76D-F33E-4B4A-B0EE-FB863345F194,473FE833-FCC6-485E-93D2-95E662C3EF53,TCGA-FE-A233-01A-11D-A33C-08,TCGA-FE-A233,TCGA-THCA,NA,Ohio State University,United States,T2,NX,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A33C-08,FALSE,0.061424855
13722.58cfa82ee4b0c9d6adf6aed4,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A2CP-01A,2F59F12D-CA0C-4AC6-9718-98A6D455AF46,Thyroid,26,043765F1-FFBD-4AC9-B0AE-733C3643083D,B8CD6882-BE27-4742-BC63-3227D31BF704,TCGA-EM-A2CP-01A-11D-A17V-08,TCGA-EM-A2CP,TCGA-THCA,NA,University Health Network,Canada,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A17V-08,TRUE,0.053960113
13722.58cfa82de4b0c9d6adf6a72e,1.8,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-21-1078-01A,0AB8D063-62B4-4D47-82AA-E3351A60029D,Lung,77,EFACAC80-9428-4482-9AEA-6B57FD172D49,8CF9B32D-3D6F-4898-8C7A-89511B754021,TCGA-21-1078-01A-01D-1521-08,TCGA-21-1078,TCGA-LUSC,474,Fox Chase Cancer Center,United States,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,1521-08,TRUE,0.995849546
13722.58cfa82de4b0c9d6adf6a742,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-64-1678-01A,F77CF4D3-9829-4FD3-95A1-B29AED9E94B8,Lung,70,0A2D9FAD-C5DF-46C1-BF96-529C7C92DFBA,53BB7112-3E38-45FE-A9C4-1B0871BABF4A,TCGA-64-1678-01A-01D-1040-01,TCGA-64-1678,TCGA-LUAD,NA,Fox Chase,United States,T2b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIA,1040-01,FALSE,0.029016686
13722.58cfa82de4b0c9d6adf6a74e,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-56-1622-01A,3EDF933A-BE1A-46E8-BFB0-ACDFF30E64A0,Lung,58,4083DE2F-3FF5-487B-A27B-783D51C4F853,0BBC7EDE-5022-4084-925C-D65BAAF7ABC2,TCGA-56-1622-01A-01D-1521-08,TCGA-56-1622,TCGA-LUSC,881,International Genomics Consortium,United States,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,1521-08,TRUE,0.057399033
13722.58cfa82de4b0c9d6adf6a776,1.9,Alive,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4420-01A,3D2AA654-1B5F-4EB4-A1C2-AF31F5760069,Lung,41,4B202550-9744-4C6C-AD17-97F764EA3F18,DE614A3E-1C0D-49C7-A2F1-28BC58E6E5C7,TCGA-05-4420-01A-01D-1931-08,TCGA-05-4420,TCGA-LUAD,NA,Indivumed,Germany,T2,N0,Lung Adenocarcinoma Mixed Subtype,Stage IB,1931-08,TRUE,0.400441421
13722.58cfa82de4b0c9d6adf6a77c,1.9,Dead,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-49-4510-01A,F77B6930-A1CE-446E-A15D-C018CBBECFEE,Lung,51,9A479D32-13A4-46C2-B26D-34CB6051A891,3E680217-92C1-4C6F-BF67-CA64E469B4A4,TCGA-49-4510-01A-01D-1931-08,TCGA-49-4510,TCGA-LUAD,896,Johns Hopkins,United States,T2,N1,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IIB,1931-08,TRUE,0.187632645
13722.58cfa82de4b0c9d6adf6a77a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-60-2711-01A,1F11DE87-A5FE-49FD-80C1-E279B2BC69DE,Lung,64,8A3A376A-A4DB-4D4F-85CE-A894A2AA60BB,D54CA81C-1BCC-41EA-B17A-9F7249EBE9C1,TCGA-60-2711-01A-01D-0963-08,TCGA-60-2711,TCGA-LUSC,NA,Roswell Park,United States,T2,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IB,0963-08,FALSE,0.147820686
13722.58cfa82ee4b0c9d6adf6a7cf,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CR-7391-01A,832316EE-08AB-412B-9E4D-8A57FF84BC11,Head and Neck,36,54B7DB2E-F0DD-469D-81BB-4E2A86EBEA9D,C121DE15-78F7-4698-91BF-FD0485C466C2,TCGA-CR-7391-01A-11D-2334-08,TCGA-CR-7391,TCGA-HNSC,NA,Vanderbilt University,United States,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,2334-08,FALSE,0.234678824
13722.58cfa82ee4b0c9d6adf6a81a,1.9,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-BA-4077-01B,4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A,Head and Neck,45,327BBCA7-FA25-4A92-BE27-21A4C184C760,268D9CDB-CCCF-491A-A9BB-2E3D6B85951F,TCGA-BA-4077-01B-01D-2268-08,TCGA-BA-4077,TCGA-HNSC,1134,UNC,None,T4a,N0,Head and Neck Squamous Cell Carcinoma,Stage IVA,2268-08,TRUE,0.1519461
13722.58cfa82ee4b0c9d6adf6a8da,NA,Dead,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-78-7146-01A,FF9DEF3D-17E5-4EF6-B74E-933F11ED6F00,Lung,71,98A8D751-4EFD-442E-A242-0FE399C2586F,7692E684-4AF2-4892-80AD-1F417B6B38FA,TCGA-78-7146-01A-11D-2036-08,TCGA-78-7146,TCGA-LUAD,173,Prince Charles Hospital,Australia,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA,2036-08,TRUE,0.087155146
13722.58cfa82ee4b0c9d6adf6a89c,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-44-6148-01A,8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA,Lung,60,C0FE5FFE-C0A3-4E62-AA55-2BC18788E505,9C7B3AC8-1352-49CD-8A8C-DF6B19F6FD64,TCGA-44-6148-01A-11D-1753-08,TCGA-44-6148,TCGA-LUAD,NA,Christiana Healthcare,United States,T1b,N0,Lung Mucinous Adenocarcinoma,Stage IA,1753-08,TRUE,0.11793995
13722.58cfa82ee4b0c9d6adf6a90a,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-FD-A3N6-01A,8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567,Bladder,43,6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D,D4615CA0-B5C7-4A5C-8593-BD50034A78AE,TCGA-FD-A3N6-01A-11D-A21A-08,TCGA-FD-A3N6,TCGA-BLCA,NA,BLN - University Of Chicago,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A21A-08,TRUE,0.789050145
13722.58cfa82ee4b0c9d6adf6a911,1.9,Alive,MALE,WHITE,Not available,Kidney Renal Clear Cell Carcinoma,TCGA-BP-4977-01A,CC353686-E2B6-46A1-8095-48E2BC44B11F,Kidney,57,35C747C0-38BB-4D2E-A428-8E24106ADFAB,1E046AB9-FA4C-4C15-8D78-ED0048C80EBF,TCGA-BP-4977-01A-01D-2048-08,TCGA-BP-4977,TCGA-KIRC,NA,MSKCC,None,T1b,NX,Kidney Clear Cell Renal Carcinoma,Stage I,2048-08,FALSE,0.117515582
13722.58cfa82ee4b0c9d6adf6a922,1.91,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0744-01A,5613F5F6-086D-470B-8F77-6DCB7F8625B7,Brain,66,C01952D4-AE81-48E2-8818-0E438E66B516,914421D2-898E-433E-BB66-B1710EAAE2C7,TCGA-06-0744-01A-01D-1492-08,TCGA-06-0744,TCGA-GBM,NA,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1492-08,FALSE,0.071442308
13722.58cfa82ee4b0c9d6adf6a9d5,NA,Alive,FEMALE,WHITE,Not available,Lung Adenocarcinoma,TCGA-55-7281-01A,659668E8-F0D9-4FF2-BBC8-9246F2EF49AB,Lung,70,AFEC3B25-C3F7-4E48-8FB0-6FB4DD581081,D5443922-FEA5-4FF0-BD6E-8CE04E1951D8,TCGA-55-7281-01A-11D-2036-08,TCGA-55-7281,TCGA-LUAD,NA,International Genomics Consortium,United States,T1b,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IA,2036-08,TRUE,0.115187819
13722.58cfa82ee4b0c9d6adf6a9e7,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4395-01A,762DEA8A-5B41-4058-979A-B7876ED13D7E,Lung,76,9DED6605-39A3-4C0F-AD2E-7F6863960DBE,BCE88385-4A1B-4A8C-920C-060F6A2675D4,TCGA-05-4395-01A-01D-2364-08,TCGA-05-4395,TCGA-LUAD,0,Indivumed,Germany,T4,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIB,2364-08,FALSE,0.145823732
13722.58cfa82ee4b0c9d6adf6aa44,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CR-7404-01A,D189A6C6-210F-4957-B500-457D5CE3F867,Head and Neck,53,A39131B9-E7C7-4385-A1B9-D8A0A0950337,83ECA7B5-45BB-44C0-8AFE-36F8988D0078,TCGA-CR-7404-01A-11D-2334-08,TCGA-CR-7404,TCGA-HNSC,NA,Vanderbilt University,United States,TX,NX,Head and Neck Squamous Cell Carcinoma,Not available,2334-08,FALSE,0.291235834
13722.58cfa82ee4b0c9d6adf6aa4d,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-19-2629-01A,E17A6048-7A72-42C0-AD3F-97CBFF02BC9F,Brain,60,B89A4D5D-EE24-4052-B454-B67169328737,56FFAA35-814C-4C0B-B3C6-D4514D34FEC2,TCGA-19-2629-01A-01D-1495-08,TCGA-19-2629,TCGA-GBM,737,Case Western,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1495-08,FALSE,0.144057588
13722.58cfa82ee4b0c9d6adf6aac9,1.9,Dead,MALE,Not available,Not available,Lung Adenocarcinoma,TCGA-05-4396-01A,9F81C602-8AFA-4588-B0B6-6E5A1A128D5A,Lung,76,4D85772B-287E-4790-B1E8-CD1C0E88AD48,0176CF1D-0760-4769-A493-277F4BB7585E,TCGA-05-4396-01A-21D-1855-08,TCGA-05-4396,TCGA-LUAD,303,Indivumed,Germany,T4,N1,Lung Adenocarcinoma Mixed Subtype,Stage IIIB,1855-08,FALSE,0.071446483
13722.58cfa82ee4b0c9d6adf6ab02,NA,Dead,MALE,WHITE,Not available,Head and Neck Squamous Cell Carcinoma,TCGA-CV-7100-01A,90A8D2CB-1F31-45F9-8575-EED3CB9A7798,Head and Neck,66,08C3093D-4100-4BFC-92FC-A11F1393868F,FECCC27E-5C2E-4339-8746-0945FEE93C1E,TCGA-CV-7100-01A-11D-2268-08,TCGA-CV-7100,TCGA-HNSC,274,MD Anderson Cancer Center,United States,T2,N1,Head and Neck Squamous Cell Carcinoma,Stage III,2268-08,TRUE,0.173005784
13722.58cfa82ee4b0c9d6adf6ab88,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-CH-5750-01A,DC40CF49-B208-4F59-B5F0-CFBDD02970B2,Prostate,72,0386D0E9-7BD8-467F-BA97-A379C1D67A83,E1B169C3-44E0-43E5-9EE3-2DF7A678A5EA,TCGA-CH-5750-01A-11D-1576-08,TCGA-CH-5750,TCGA-PRAD,NA,Indivumed,Germany,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,1576-08,TRUE,0.063014932
13722.58cfa82ee4b0c9d6adf6ab9c,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-67-6215-01A,DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2,Lung,52,3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632,68C2A355-862C-4657-B296-5776ED8447B0,TCGA-67-6215-01A-11D-1753-08,TCGA-67-6215,TCGA-LUAD,NA,St Joseph's Medical Center (MD),United States,T2a,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1753-08,TRUE,0.090502642
13722.58cfa82ee4b0c9d6adf6ab8a,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-26-5132-01A,2C5FA2D4-8E35-42E4-8BCA-9FB3371A19C8,Brain,74,AC7EA2F0-A526-4B9A-8E81-2736EA38F53B,D1132127-1250-43AF-9C16-425798A3D1A7,TCGA-26-5132-01A-01D-1486-08,TCGA-26-5132,TCGA-GBM,NA,University of Florida,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1486-08,FALSE,0.109026961
13722.58cfa82ee4b0c9d6adf6abb0,1.91,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0686-01A,C931F3BD-74C5-4EBD-BC0F-C7C6BECD25AB,Brain,53,7AF6D7A5-B550-42D9-983A-241EC76FD7F4,2C71D542-1653-4D97-8752-F2FD05C7E75D,TCGA-06-0686-01A-01D-1492-08,TCGA-06-0686,TCGA-GBM,NA,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,1492-08,FALSE,0.091353046
13722.58cfa82ee4b0c9d6adf6abc4,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-EJ-5506-01A,E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27,Prostate,67,9EBDA113-B0FC-4233-87AC-DAD0E7D033DE,9F5E6063-D19E-4F56-B3F9-5C2260D3BFC9,TCGA-EJ-5506-01A-01D-1576-08,TCGA-EJ-5506,TCGA-PRAD,NA,University of Pittsburgh,United States,T3b,N1,Prostate Adenocarcinoma Acinar Type,Not available,1576-08,TRUE,0.095907545
13722.58cfa82ee4b0c9d6adf6ac1c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7079-01A,10FBE481-F111-4F88-AE45-4D67CB265567,Prostate,51,190EF71A-5B5D-4009-B707-68F10147CB65,7F1CA00A-84BA-4B26-A1A5-4D83C363AC69,TCGA-HC-7079-01A-11D-1961-08,TCGA-HC-7079,TCGA-PRAD,NA,International Genomics Consortium,United States,T3a,N0,Prostate Adenocarcinoma Acinar Type,Not available,1961-08,FALSE,0.045997785
13722.58cfa82ee4b0c9d6adf6ac1e,NA,Alive,MALE,Not available,Not available,Prostate Adenocarcinoma,TCGA-G9-7522-01A,87959988-BB25-47EE-AFC1-9AF92592BBE7,Prostate,49,10BFE256-C4A2-4D88-B907-56F86EF63DE9,F54442D1-80FA-4678-AC94-C3AD03BC37FB,TCGA-G9-7522-01A-11D-2260-08,TCGA-G9-7522,TCGA-PRAD,NA,Roswell Park,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2260-08,FALSE,0.053842069
13722.58cfa82ee4b0c9d6adf6ac27,NA,Alive,MALE,BLACK OR AFRICAN AMERICAN,Not available,Prostate Adenocarcinoma,TCGA-HC-7737-01A,73F875CB-BCFC-43BA-AB97-4E94CAF836D4,Prostate,55,47B6E89A-EA86-475A-9F1D-02001069C895,DCF98ACC-736B-4AF6-BDCA-A320A413165A,TCGA-HC-7737-01A-11D-2114-08,TCGA-HC-7737,TCGA-PRAD,NA,International Genomics Consortium,United States,T2c,N1,Prostate Adenocarcinoma Acinar Type,Not available,2114-08,FALSE,0.053269445
13722.58cfa82ee4b0c9d6adf6ac9a,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-91-6847-01A,97831D28-AB41-4C18-BFC2-C4C6BC757D13,Lung,62,96A05D4B-3731-4B98-B38F-A6B33CD6ED96,020FAB36-C7DE-4933-B2BF-DC7B019A1326,TCGA-91-6847-01A-11D-1945-08,TCGA-91-6847,TCGA-LUAD,NA,ABS - IUPUI,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IB,1945-08,TRUE,0.040420831
13722.58cfa82ee4b0c9d6adf6acac,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Prostate Adenocarcinoma,TCGA-HC-7740-01A,91E249A6-B0B0-487E-9FAD-0E9F5798DCAE,Prostate,59,54D1CF0E-5D54-486C-A863-733B5EDC5986,7303F9FE-88BB-48BA-B9B4-EBF9E4770C1C,TCGA-HC-7740-01A-11D-2114-08,TCGA-HC-7740,TCGA-PRAD,NA,International Genomics Consortium,United States,T2c,N0,Prostate Adenocarcinoma Acinar Type,Not available,2114-08,FALSE,0.135301809
13722.58cfa82ee4b0c9d6adf6accb,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6815-01A,53086E20-A727-40D6-B42D-8030109B5130,Stomach,70,B5F3D9A1-46B5-4A63-8F7D-9C993FE9340D,9536F736-63BC-4099-BD54-740F5910F4A8,TCGA-D7-6815-01A-11D-1882-08,TCGA-D7-6815,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N2,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IIB,1882-08,FALSE,0.054219513
13722.58cfa82ee4b0c9d6adf6acd3,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6528-01A,35496E4E-598F-4FFC-B11E-8EDAEB676079,Stomach,70,DF817250-9A2C-42E8-AD90-0D9E13FE37B3,153A64EE-6322-4F2E-B3DF-77EF7D3A4CF0,TCGA-D7-6528-01A-11D-1800-08,TCGA-D7-6528,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N0,Stomach  Intestinal Adenocarcinoma  Tubular Type,Stage IB,1800-08,TRUE,1.056130632
13722.58cfa82ee4b0c9d6adf6acdb,1.9,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6519-01A,E37CAE9E-0656-4B89-B326-739A5CC859E0,Stomach,64,FA7426E1-FCFB-4B08-AD50-1D9E903A81FB,A2E67393-50D7-4BCC-9BBD-C695086A936A,TCGA-D7-6519-01A-11D-1800-08,TCGA-D7-6519,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIIB,1800-08,TRUE,0.07371177
13722.58cfa82ee4b0c9d6adf6ad0e,1.91,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1AE-01A,493A4FF2-37A5-4B79-928D-83DBFE534556,Bladder,84,67865453-D515-4D63-84E8-CFB2686A211D,ABD2D959-D5ED-4EB3-9759-67EB1AA23325,TCGA-DK-A1AE-01A-11D-A13W-08,TCGA-DK-A1AE,TCGA-BLCA,NA,Memorial Sloan Kettering,United States,T3,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage III,A13W-08,TRUE,0.136293763
13722.58cfa82ee4b0c9d6adf6ac7c,1.8,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-6591-01A,9B132E4F-7E35-4CC5-8711-43AD62B906D0,Lung,63,0791E7AA-E97C-4DD0-9615-09EC7090F684,BF7462A2-394F-4838-BCB6-4D0126FA48B1,TCGA-50-6591-01A-11D-1753-08,TCGA-50-6591,TCGA-LUAD,119,University of Pittsburgh,United States,T2,N0,Lung Adenocarcinoma- Not Otherwise Specified (NOS),Stage IV,1753-08,TRUE,0.06535991
13722.58cfa82ee4b0c9d6adf6af6a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-55-6972-01A,C4D1E105-28B7-48DF-ABEF-FBE09782FDB2,Lung,72,38C83B40-FBA4-48D4-AD6E-93768CB6139F,46693A2B-5105-4770-A9E1-031DFEDEB694,TCGA-55-6972-01A-11D-1945-08,TCGA-55-6972,TCGA-LUAD,NA,International Genomics Consortium,United States,T2,N0,Lung Papillary Adenocarcinoma,Stage IB,1945-08,TRUE,0.033218939
13722.58cfa82ee4b0c9d6adf6b0c4,1.9,Alive,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2756-01A,43ABE847-4BA7-466E-8283-5D7B80B999A7,Lung,68,D80486CD-F054-4527-A886-CF9446381B9F,25224AA0-CFDD-48EC-92E5-8F3992A3E574,TCGA-66-2756-01A-01D-1180-08,TCGA-66-2756,TCGA-LUSC,NA,Indivumed,Germany,T4,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB,1180-08,FALSE,0.085107934
13722.58cfa82ee4b0c9d6adf6af76,2,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Adenocarcinoma,TCGA-50-5930-01A,368E23F0-E573-4547-BF5A-14080BAF737B,Lung,47,3E30DBD1-10BF-4450-8D19-6F44D3284E02,BD3E88B3-B37C-4641-85FA-D8125BA324CA,TCGA-50-5930-01A-11D-1753-08,TCGA-50-5930,TCGA-LUAD,282,University of Pittsburgh,United States,T2,N2,Lung Adenocarcinoma Mixed Subtype,Stage IIIA,1753-08,TRUE,0.016233651
13722.58cfa82de4b0c9d6adf6a720,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-60-2726-01A,3D1F4059-2220-45B4-A4D2-B14F76CEC96A,Lung,56,91A60807-2D0F-474E-B02F-18FEA788B319,A96EDDFC-3AFB-4BF8-A440-C91778113FBD,TCGA-60-2726-01A-01D-1522-08,TCGA-60-2726,TCGA-LUSC,358,Roswell Park,United States,T2,N1,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIA,1522-08,TRUE,0.692610447
13722.58cfa82ee4b0c9d6adf6abe7,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A2CU-01A,667EB7F6-1D36-49BB-9D7B-C9D167B64619,Thyroid,47,5F75F169-6835-4B42-AF77-AB64CBFB5EF3,788FBFAA-51BF-42A4-AFA6-5B87ED04C2D5,TCGA-EM-A2CU-01A-12D-A17V-08,TCGA-EM-A2CU,TCGA-THCA,NA,University Health Network,Canada,T2,N1a,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III,A17V-08,TRUE,0.429195028
13722.58cfa82ee4b0c9d6adf6ac7e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-85-8052-01A,395BABB3-3F5D-4E71-A675-AF4443F23028,Lung,53,9248B38E-EC7B-4C7C-BCB0-E942CE3C4847,43AA4123-0FE2-4071-8A81-CBDD0410B917,TCGA-85-8052-01A-11D-2244-08,TCGA-85-8052,TCGA-LUSC,NA,Asterand,Russia,T3,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIB,2244-08,FALSE,0.023814071
13722.58cfa82ee4b0c9d6adf6ac7a,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-IN-7806-01A,87C217D4-66F4-46CA-8244-7856CE658FD3,Stomach,50,9B864C79-BF5C-4430-86E8-D8479ED90D25,576A1741-8C65-40DA-9F0F-B2CA805D70F3,TCGA-IN-7806-01A-11D-2053-08,TCGA-IN-7806,TCGA-STAD,NA,University of Pittsburgh,United States,T3,N1,Stomach  Adenocarcinoma  Diffuse Type,Stage IIB,2053-08,FALSE,0.228601301
13722.58cfa82ee4b0c9d6adf6ac9c,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-21-1083-01A,0398EAE1-7216-4595-80A5-6B117D96E070,Lung,75,300CB22F-ACB4-4ACD-8D64-FE8DCDF64801,FB0C6353-A90C-45E2-9355-7CD16CF756FF,TCGA-21-1083-01A-01D-1521-08,TCGA-21-1083,TCGA-LUSC,1315,Fox Chase Cancer Center,United States,T1,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,1521-08,TRUE,0.042420831
13722.58cfa82ee4b0c9d6adf6acec,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DE-A3KN-01A,085FFCDC-8600-42E2-852A-506465F716A2,Thyroid,49,620B21C9-AC06-4154-A941-2532C775C6D8,07A7C634-BD9A-4FC2-B9FE-87B060EC3D1F,TCGA-DE-A3KN-01A-11D-A20C-08,TCGA-DE-A3KN,TCGA-THCA,NA,University of North Carolina,United States,T3,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A20C-08,FALSE,0.653278891
13722.58cfa82ee4b0c9d6adf6acef,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A4UT-01A,ACB80B76-2394-4250-8687-60E40E16E83B,Thyroid,32,4D6855A8-076D-4F95-B6CE-2B250CE3087D,64A17D5B-8F40-4CCF-8F2F-E68C5FE6B1FF,TCGA-DJ-A4UT-01A-11D-A257-08,TCGA-DJ-A4UT,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A257-08,FALSE,0.053960113
13722.58cfa82ee4b0c9d6adf6acf8,NA,Dead,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EL-A3T9-01A,8A233B01-2959-467F-8950-02BE16309156,Thyroid,69,5297F55C-3A46-47ED-8ACC-03333AC26473,D692ECD0-2433-426B-9AF2-A30C44A80F7C,TCGA-EL-A3T9-01A-21D-A22D-08,TCGA-EL-A3T9,TCGA-THCA,174,MD Anderson,United States,T4,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage IV,A22D-08,TRUE,0.109975366
13722.58cfa82ee4b0c9d6adf6ad00,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-E8-A418-01A,EBBD54AD-7B97-4081-AD11-7F7F3CE74EEF,Thyroid,75,979CBB75-28D9-4D33-8083-077C25BDDFD6,63EA274B-D42B-4787-9C54-8EE95EA376EC,TCGA-E8-A418-01A-11D-A23M-08,TCGA-E8-A418,TCGA-THCA,NA,Asterand,Russia,T4a,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage IVA,A23M-08,FALSE,0.097922012
13722.58cfa82ee4b0c9d6adf6ad02,NA,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-E8-A416-01A,86B82345-6F4D-44FD-A9DB-6F107DE62F53,Thyroid,51,AF7B5868-2C11-4C74-8033-E914C987ECE6,C8381701-31CB-465A-BDF2-1B8132BE7A14,TCGA-E8-A416-01A-11D-A23M-08,TCGA-E8-A416,TCGA-THCA,NA,Asterand,Vietnam,T1b,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A23M-08,FALSE,0.075413277
13722.58cfa82ee4b0c9d6adf6ad1c,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-BJ-A45K-01A,8CFB88F6-7B37-4F1E-882B-3A368B604167,Thyroid,33,29B4816D-4CFB-45F0-BCD2-6B948245F3A4,77EBE6D2-6537-49D3-849D-FE93E2CF52AF,TCGA-BJ-A45K-01A-11D-A23U-08,TCGA-BJ-A45K,TCGA-THCA,NA,University of Pittsburgh,United States,T2,N0,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A23U-08,FALSE,0.061224775
13722.58cfa82ee4b0c9d6adf6ad12,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DE-A2OL-01A,77BB90F0-E923-4E28-BB88-4D6B420E0B5C,Thyroid,44,6CBA95AD-2702-4F50-8B1E-BECDAF014B83,FC812906-D3B6-4210-A842-96F095280CBF,TCGA-DE-A2OL-01A-11D-A18F-08,TCGA-DE-A2OL,TCGA-THCA,NA,University of North Carolina,United States,T2,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A18F-08,FALSE,0.097502642
13722.58cfa82ee4b0c9d6adf6ad18,NA,Alive,FEMALE,ASIAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EM-A2OV-01A,55E03FFC-F006-4EC8-8E5D-A738FF091F8A,Thyroid,64,1183BCB5-50A7-4CC0-A94C-732636B7EE7D,2DFE70FD-2650-49C0-B6EB-67DF585D063B,TCGA-EM-A2OV-01A-11D-A202-08,TCGA-EM-A2OV,TCGA-THCA,NA,University Health Network,Canada,T2,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage II,A202-08,TRUE,0.08671177
13722.58cfa82ee4b0c9d6adf6ad1f,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-8486-01A,B8A1C8C7-3945-4D84-8F58-3A1A1EB10730,Stomach,90,65FA5F32-8747-41B7-8287-061587DC22DE,6A7CDAF6-211E-4EB8-A70E-1153D69C45E4,TCGA-BR-8486-01A-31D-2394-08,TCGA-BR-8486,TCGA-STAD,NA,Asterand,Russia,T1b,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA,2394-08,TRUE,0.277788629
13722.58cfa82ee4b0c9d6adf6adac,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-CD-8529-01A,5B7E557A-6AEE-4077-B3CD-C96179E643AE,Stomach,65,EB18C784-32F7-4570-A661-E4DF8F55378C,931B24DA-5D6D-4C2D-8DE9-EF32D6EB8565,TCGA-CD-8529-01A-11D-2340-08,TCGA-CD-8529,TCGA-STAD,NA,ILSbio,Vietnam,T4,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IV,2340-08,FALSE,0.041043387
13722.58cfa82ee4b0c9d6adf6add6,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-8690-01A,337819D2-5281-4B41-9583-A476924BC837,Stomach,54,0F7EBFFA-D119-45D6-8AF1-2048ECA173E7,EDC8839F-FA6B-41E0-AD49-F688073730BD,TCGA-BR-8690-01A-11D-2394-08,TCGA-BR-8690,TCGA-STAD,NA,Asterand,Ukraine,T3,N3a,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IIIB,2394-08,TRUE,0.174451156
13722.58cfa82ee4b0c9d6adf6ad25,1.9,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-19-1389-01A,309005A2-93A8-4566-B8D3-6B9310144266,Brain,51,A20EB141-2F2C-44E4-BBC2-5BC9F58F5644,359452A5-29CD-4D2B-BB78-E60FD790A35E,TCGA-19-1389-01A-01D-2319-08,TCGA-19-1389,TCGA-GBM,141,Case Western,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,2319-08,FALSE,0.089664921
13722.58cfa82ee4b0c9d6adf6ae16,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Lung Squamous Cell Carcinoma,TCGA-94-7943-01A,AECF85CC-058C-46F3-9CDC-3573AC3B8438,Lung,80,E447DA47-227D-4956-9F46-AD1F81B73EBA,7731EF7F-25BD-42F5-9A20-BE249306A711,TCGA-94-7943-01A-11D-A320-08,TCGA-94-7943,TCGA-LUSC,NA,Washington University - Emory,United States,T1b,NX,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,A320-08,TRUE,0.071513142
13722.58cfa82ee4b0c9d6adf6ade4,1.8,Dead,MALE,Not available,Not available,Lung Squamous Cell Carcinoma,TCGA-66-2789-01A,87AC0AD4-8C9D-409E-9A86-1D201D01769D,Lung,73,A633A5CA-C207-45BE-8903-93527DE31C22,9623D295-C23D-4F2F-827C-69F767A26F1F,TCGA-66-2789-01A-01D-A320-08,TCGA-66-2789,TCGA-LUSC,123,Indivumed,Germany,T1,N3,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IIIB,A320-08,TRUE,0.101028224
13722.58cfa82ee4b0c9d6adf6ad92,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-D7-6527-01A,CB622CD6-776D-4681-8A67-4ADDD61C66B8,Stomach,62,8461CE68-3A6F-4343-8977-78448123F373,DC537FCF-D910-4C4B-8AF9-E7DA429F2633,TCGA-D7-6527-01A-11D-1800-08,TCGA-D7-6527,TCGA-STAD,NA,Greater Poland Cancer Center,Poland,T2,N1,Stomach Intestinal Adenocarcinoma Papillary Type,Stage II,1800-08,TRUE,0.100180296
13722.58cfa82ee4b0c9d6adf6ae7c,1.92,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Glioblastoma Multiforme,TCGA-06-0171-01A,01A92062-967A-4900-8DC7-A5ECD3B3F8E2,Brain,65,6081351A-7D07-41FB-A99E-43587223BFCC,18901F76-660B-4CC6-AF1B-1B6F5D62204D,TCGA-06-0171-01A-02D-A33C-08,TCGA-06-0171,TCGA-GBM,399,Henry Ford Hospital,None,Not available,Not available,Untreated primary (de novo) GBM,Not available,A33C-08,FALSE,0.067047412
13722.58cfa82ee4b0c9d6adf6aeaa,NA,Alive,FEMALE,WHITE,Not available,Thyroid Carcinoma,TCGA-ET-A4KN-01A,7629F864-A009-4AA9-BF7E-2D99E00D294E,Thyroid,51,E01D507C-8E8E-45C6-B4EF-193177A382C4,178D0486-CB0D-4979-8BDF-BB3FE99149BD,TCGA-ET-A4KN-01A-11D-A257-08,TCGA-ET-A4KN,TCGA-THCA,NA,Johns Hopkins,United States,T3,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage III,A257-08,FALSE,0.056269445
13722.58cfa82ee4b0c9d6adf6aea0,NA,Alive,FEMALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-FY-A2QD-01A,B0CB6ED7-3D9F-4D5E-8DF5-EDCC921C43B4,Thyroid,61,08D3CB3B-9A80-4034-B06D-B37DD38C8B9B,E7335A24-E5FC-4558-9EBA-511C5A802320,TCGA-FY-A2QD-01A-11D-A19J-08,TCGA-FY-A2QD,TCGA-THCA,NA,International Genomics Consortium,United States,T1,N0,Thyroid Papillary Carcinoma - Classical/usual,Not available,A19J-08,FALSE,0.084022917
13722.58cfa82ee4b0c9d6adf6aedb,NA,Alive,FEMALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A2Q1-01A,E35B2928-8784-45D0-A71A-A2DF161542FA,Thyroid,44,D1361CB2-6758-4A8C-AE97-8AD5192572FC,007AAB66-2F07-459D-8952-3041D6EA24A8,TCGA-DJ-A2Q1-01A-22D-A19J-08,TCGA-DJ-A2Q1,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N1b,Thyroid Papillary Carcinoma - Classical/usual,Stage I,A19J-08,FALSE,0.04806864
13722.58cfa82ee4b0c9d6adf6aeb6,NA,Alive,MALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A2CN-01A,4AED5116-D27B-4911-B310-05C2248B861F,Thyroid,62,4548D9EE-668F-495B-845F-8B9FC798EA38,5C02D399-07AF-4573-A568-BC1B256BC8F8,TCGA-EM-A2CN-01A-11D-A19J-08,TCGA-EM-A2CN,TCGA-THCA,NA,University Health Network,Canada,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage IVC,A19J-08,FALSE,0.062669968
13722.58cfa82ee4b0c9d6adf6af3e,1.9,Dead,FEMALE,WHITE,Not available,Lung Squamous Cell Carcinoma,TCGA-22-5485-01A,305F72A8-069B-410B-BBE4-4ECB761C748D,Lung,58,ABC3A25F-D5BC-469E-8C3E-8E6F5B129E8F,448AF8B4-E071-48B0-A65B-B4AD17AFDC0C,TCGA-22-5485-01A-01D-1632-08,TCGA-22-5485,TCGA-LUSC,916,Mayo Clinic - Rochester,United States,T1a,N0,Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS),Stage IA,1632-08,FALSE,0.012407758
13722.58cfa82ee4b0c9d6adf6af4e,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-EL-A4K6-01A,4FC8E011-4433-4537-B03F-457A3A70240F,Thyroid,75,BB98FF62-4CD8-46D6-9A85-8439265BE40B,66EB4833-1B87-4FD9-A53D-26DC7AD6DE29,TCGA-EL-A4K6-01A-12D-A257-08,TCGA-EL-A4K6,TCGA-THCA,NA,MD Anderson,United States,T4,N1,Thyroid Papillary Carcinoma - Classical/usual,Stage IV,A257-08,FALSE,0.055397981
13722.58cfa82ee4b0c9d6adf6aec4,1.95,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13R-01A,3E787A0E-B5D2-401E-B1E5-077376090B3A,Thyroid,50,27B0FF79-4213-4B57-B6E0-A393B8983D20,3F039593-91D1-43CB-A06B-41E92F7E8D20,TCGA-DJ-A13R-01A-11D-A10S-08,TCGA-DJ-A13R,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T3,N0,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage III,A10S-08,TRUE,0.012407758
13722.58cfa82ee4b0c9d6adf6af6e,NA,Dead,MALE,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-F1-6875-01A,283776CD-32E8-4A79-BED1-1411C9D3A9E0,Stomach,79,4E5FDD56-C807-4493-A331-359577C31514,EA1CAC20-88C1-4257-9CDB-D2890EB2E123,TCGA-F1-6875-01A-11D-2053-08,TCGA-F1-6875,TCGA-STAD,2197,UNC,United States,T2,N0,Stomach  Adenocarcinoma  Not Otherwise Specified (NOS),Stage IA,2053-08,FALSE,0.121614662
13722.58cfa82ee4b0c9d6adf6b004,NA,Alive,FEMALE,Not available,Not available,Thyroid Carcinoma,TCGA-EM-A3FL-01A,CFDD2155-57A9-499C-92E1-FB82B577B050,Thyroid,63,56E31332-09FB-4305-8EE8-ADC568B393F3,1BBB522D-E224-4B3F-9E10-3A47D06B2B05,TCGA-EM-A3FL-01A-11D-A21A-08,TCGA-EM-A3FL,TCGA-THCA,NA,University Health Network,Canada,T1b,NX,Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned),Stage I,A21A-08,TRUE,0.071559264
13722.58cfa82ee4b0c9d6adf6afc7,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Thyroid Carcinoma,TCGA-DJ-A13L-01A,C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B,Thyroid,85,AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8,1924D200-6929-4EEF-8A7F-317F8FBAB915,TCGA-DJ-A13L-01A-11D-A21Z-08,TCGA-DJ-A13L,TCGA-THCA,NA,Memorial Sloan Kettering,United States,T1b,N0,Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features),Stage I,A21Z-08,TRUE,0.049823528
13722.58cfa82ee4b0c9d6adf6ade1,NA,Alive,MALE,ASIAN,NOT HISPANIC OR LATINO,Stomach Adenocarcinoma,TCGA-BR-8682-01A,D5EFCDE2-21E6-4071-9AA4-3C5688A45B3F,Stomach,52,4E6BBC3C-BB9E-46C0-8B22-60F9725DB516,EA2055D1-7B8B-4AAF-9A70-8802F4DEEF9B,TCGA-BR-8682-01A-11D-2394-08,TCGA-BR-8682,TCGA-STAD,NA,Asterand,Vietnam,T4a,N0,Stomach Intestinal Adenocarcinoma Mucinous Type,Stage IIB,2394-08,TRUE,0.217709134
13722.58cfa82ee4b0c9d6adf6aaa8,1.91,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Bladder Urothelial Carcinoma,TCGA-DK-A1A5-01A,904A8757-E0C5-41EF-B583-C8F170CAAAC1,Bladder,79,A9EF3EC5-B1C1-481F-89CF-1729FAB50173,448FE471-3F4E-4DC8-A4E0-6F147DC93ABE,TCGA-DK-A1A5-01A-11D-A13W-08,TCGA-DK-A1A5,TCGA-BLCA,65,Memorial Sloan Kettering,United States,T2b,N0,Muscle invasive urothelial carcinoma (pT2 or above),Stage II,A13W-08,TRUE,0.290605747
13722.58cfa82ee4b0c9d6adf6ab36,NA,Dead,MALE,WHITE,NOT HISPANIC OR LATINO,Skin Cutaneous Melanoma,TCGA-ER-A19T-01A,B85B14D7-3B5A-4800-AF12-622EC03B9FE5,Skin,51,11E2F891-251A-4813-AA90-E944F350C54D,D1942D67-3C90-474E-9164-E76DDF9E335A,TCGA-ER-A19T-01A-11D-A19A-08,TCGA-ER-A19T,TCGA-SKCM,270,University of Pittsburgh,United States,T4a,N3,Not available,Stage IV,A19A-08,TRUE,0.07771177
13722.58cfa82ee4b0c9d6adf6ab7e,1.9,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CQ-5323-01A,DEEFDD62-4D35-40C9-AD4C-0B593F35CFF7,Head and Neck,82,3AC5396D-B92F-41D5-A3F0-603AA52AAFA3,892067EF-C465-46EA-8F91-10636DD0081B,TCGA-CQ-5323-01A-01D-1683-08,TCGA-CQ-5323,TCGA-HNSC,NA,"University Health Network, Toronto",Canada,T1,N0,Head and Neck Squamous Cell Carcinoma,Stage I,1683-08,FALSE,0.116952168
13722.58cfa82ee4b0c9d6adf6abf5,NA,Alive,MALE,WHITE,NOT HISPANIC OR LATINO,Head and Neck Squamous Cell Carcinoma,TCGA-CR-7368-01A,27C28C89-F4E7-4AEC-A806-C0DA7756E47F,Head and Neck,54,0C4C4B41-05AC-48CE-B5C0-A639FFAFC411,4B194AB3-D213-4A7A-BE46-909B4F0C7291,TCGA-CR-7368-01A-11D-2129-08,TCGA-CR-7368,TCGA-HNSC,NA,Vanderbilt University,United States,T4a,N1,Head and Neck Squamous Cell Carcinoma,Stage IVA,2129-08,FALSE,0.120213623